More InformationROVERDialysis Water Transport System The ROVER Dialysis Water Transport System is a medical grade cart approach designed for the safe movement of a portable reverse osmosis (RO) machine and associated treatment equipment. This complete and compact solution to move water treatment equipment is necessary to assist individual hemodialysis patients in hospital based settings or wherever acute care is required. Designed with the user in mind, the ROVER design conceals required components, provides hose and cord management options, and gives the user an area to store testing supplies and paperwork. |  | ||
Developed to streamline the transporting of water equipment used in acute hemodialysis procedures and eliminate the possibility of deterioration associated with metal carts. From the initial design phase, extensive thought and user research has been put into how to improve the experience of moving and using water treatment equipment in a medical setting. ROVER, quite simply, dramatically improves the process of delivering a dialysis water treatment system
The ROVER Dialysis Water Transport System Product Introduction Video
More InformationROVERDialysis Water Transport System The ROVER Dialysis Water Transport System is a medical grade cart approach designed for the safe movement of a portable reverse osmosis (RO) machine and associated treatment equipment. This complete and compact solution to move water treatment equipment is necessary to assist individual hemodialysis patients in hospital based settings or wherever acute care is required. Designed with the user in mind, the ROVER design conceals required components, provides hose and cord management options, and gives the user an area to store testing supplies and paperwork. |
|
||
PLYMOUTH, Minn., March 30, 2016 -- Mar Cor Purification announced the release of its new ROVER™ Portable Dialysis Water Transport System, the first all-plastic, dialysis water cart designed specifically for the hospital environment. The cart was developed to streamline the transport of water purification equipment used in acute hemodialysis procedures and to eliminate the possibility of deterioration associated with metal carts. The ROVER cart improves the safety and efficiency of delivering a dialysis water treatment system within the hospital. All components are fully integrated into the cart system, making the monitoring of key parameters and execution of daily procedures more convenient. The ROVER System has smooth plastic surfaces, which allow for easy cleaning and disinfection, thereby protecting the patient from infection.
The ROVER System includes several water purification components, including an integrated PTG-520® Carbon System and depth filter, and provides the option for additional equipment, all encompassed in a fully integrated package. The system is compatible with all current Mar Cor Purification portable hemodialysis reverse osmosis systems, and was tested to UL 60601-1 and IEC 61010-1 Threshold and Stability standards-ensuring a safe experience for the user.
Curt Weitnauer, President of Mar Cor Purification, said, "The ROVER System dramatically improves the process of transporting a portable dialysis water treatment system. The concept and development of the system was driven by input from nurses and technicians involved in acute dialysis care on a daily basis. The finished product allows the operator to focus more on quality patient care and less on the equipment. The release of the ROVER system is an example of our commitment to improving patient safety while improving provider productivity in the delivery of hemodialysis care."
About Cantel Medical
Cantel Medical. (NYSE: CMN) - Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, and hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including nine ion exchange resin regeneration plants strategically located in large metropolitan areas. Mar Cor Purification also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network. Visit our website at www.mcpur.com to find out more about Mar Cor Purification.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE Mar Cor Purification, Inc.
More Information
ROVER™
Dialysis Water Transport System
The ROVER Dialysis Water Transport System is a medical grade cart approach designed for the safe movement of a portable reverse osmosis (RO) machine and associated treatment equipment. This complete and compact solution to move water treatment equipment is necessary to assist individual hemodialysis patients in hospital based settings or wherever acute care is required.
[summary] => [format] => full_html [safe_value] =>PLYMOUTH, Minn., March 30, 2016 -- Mar Cor Purification announced the release of its new ROVER™ Portable Dialysis Water Transport System, the first all-plastic, dialysis water cart designed specifically for the hospital environment. The cart was developed to streamline the transport of water purification equipment used in acute hemodialysis procedures and to eliminate the possibility of deterioration associated with metal carts. The ROVER cart improves the safety and efficiency of delivering a dialysis water treatment system within the hospital. All components are fully integrated into the cart system, making the monitoring of key parameters and execution of daily procedures more convenient. The ROVER System has smooth plastic surfaces, which allow for easy cleaning and disinfection, thereby protecting the patient from infection.
The ROVER System includes several water purification components, including an integrated PTG-520® Carbon System and depth filter, and provides the option for additional equipment, all encompassed in a fully integrated package. The system is compatible with all current Mar Cor Purification portable hemodialysis reverse osmosis systems, and was tested to UL 60601-1 and IEC 61010-1 Threshold and Stability standards-ensuring a safe experience for the user.
Curt Weitnauer, President of Mar Cor Purification, said, "The ROVER System dramatically improves the process of transporting a portable dialysis water treatment system. The concept and development of the system was driven by input from nurses and technicians involved in acute dialysis care on a daily basis. The finished product allows the operator to focus more on quality patient care and less on the equipment. The release of the ROVER system is an example of our commitment to improving patient safety while improving provider productivity in the delivery of hemodialysis care."
About Cantel Medical
Cantel Medical. (NYSE: CMN) - Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, and hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including nine ion exchange resin regeneration plants strategically located in large metropolitan areas. Mar Cor Purification also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network. Visit our website at www.mcpur.com to find out more about Mar Cor Purification.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE Mar Cor Purification, Inc.
More Information
ROVER™
Dialysis Water Transport System
The ROVER Dialysis Water Transport System is a medical grade cart approach designed for the safe movement of a portable reverse osmosis (RO) machine and associated treatment equipment. This complete and compact solution to move water treatment equipment is necessary to assist individual hemodialysis patients in hospital based settings or wherever acute care is required.
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => March 30, 2016 [format] => [safe_value] => March 30, 2016 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [description] => Array ( [value] => Designed with the user in mind, the ROVER design conceals required components, provides hose and cord management options, and gives the user an area to store testing supplies and paperwork. ) [keywords] => Array ( [value] => dialysis cart, portable dialysis cart, ro cart ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1459342740 [last_comment_name] => [last_comment_uid] => 36 [comment_count] => 0 [name] => alafreniere [picture] => 0 [data] => b:0; [entity_view_prepared] => 1 ) [3] => stdClass Object ( [vid] => 203 [uid] => 33 [title] => Cantel Medical Subsidiary Mar Cor Purification Releases New 2016 Digital Dialysis Water Catalog and Price Guide [log] => [status] => 1 [comment] => 2 [promote] => 1 [sticky] => 0 [nid] => 203 [type] => news_and_events [language] => und [created] => 1454534627 [changed] => 1461090235 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1461090235 [revision_uid] => 36 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>
… Designed to improve customer experience by providing faster access to information on Mar Cor dialysis products and services
Plymouth, MN – January 14, 2016 - Mar Cor Purification, a worldwide leader in water, filtration, and disinfection technologies, and the leading provider of hemodialysis water equipment in North America, recently released a new U.S. Dialysis Water Product Digital Catalog – 1st edition, available on the Mar Cor Purification website and at catalog.mcpur.com. The digital version of the catalog provides on demand U.S. list pricing for all catalog products and is designed to improve customer experience by providing faster access to information on Mar Cor dialysis products and services through a more user-friendly and interactive online experience
Visitors to catalog.mcpur.com will find a built-in search function giving the user a tool to find specific products quickly. “We are excited to release this new interactive tool to our customers and hope that it makes their research and procurement of dialysis water products a more efficient and enjoyable process.” - Chris Fournier, VP Marketing. Some of the benefits provided by the digital catalog include: |
|
- • Full color catalog with products specific to Dialysis Water
- • Easily navigate and search for products
- • Drilldown navigation to specific products/product categories
• Product or keyword search
• Ability to add products to a cart and request part number specific quotes that get emailed directly to Customer Service
• Cross platform functionality with mobile responsive navigation
“The intent of the project was two-fold. First, as the largest provider of hemodialysis water equipment in North America, we wanted to have a catalog that provided products specific to those hemodialysis water users and providers. Second, we wanted to improve the experience of finding product and pricing information by presenting a more interactive and easy to use tool” said Chris Fournier, VP Marketing.
Hard copies of the new Dialysis Water Product Catalog can be requested by by calling Mar Cor Customer Service at 800.633.3080. Visit catalog.mcpur.com today to check out the all new Mar Cor Purification Dialysis Water Digital Catalog, and keep up-to-date with exiting new dialysis products and services designed to ensure safe water and improve provider productivity.
About Cantel Medical
Cantel Medical (NYS: CMN) - Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, and hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com .
About Mar Cor Purification
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including nine ion exchange resin regeneration plants strategically located in large metropolitan areas. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network. Visit our website at mcpur.com to find out more about Mar Cor Purification.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE: Mar Cor Purification.
[summary] => [format] => full_html [safe_value] =>
… Designed to improve customer experience by providing faster access to information on Mar Cor dialysis products and services
|
Plymouth, MN – January 14, 2016 - Mar Cor Purification, a worldwide leader in water, filtration, and disinfection technologies, and the leading provider of hemodialysis water equipment in North America, recently released a new U.S. Dialysis Water Product Digital Catalog – 1st edition, available on the Mar Cor Purification website and at catalog.mcpur.com. The digital version of the catalog provides on demand U.S. list pricing for all catalog products and is designed to improve customer experience by providing faster access to information on Mar Cor dialysis products and services through a more user-friendly and interactive online experience
Visitors to catalog.mcpur.com will find a built-in search function giving the user a tool to find specific products quickly. “We are excited to release this new interactive tool to our customers and hope that it makes their research and procurement of dialysis water products a more efficient and enjoyable process.” - Chris Fournier, VP Marketing. Some of the benefits provided by the digital catalog include: |
|
- • Full color catalog with products specific to Dialysis Water
- • Easily navigate and search for products
- • Drilldown navigation to specific products/product categories
• Product or keyword search
• Ability to add products to a cart and request part number specific quotes that get emailed directly to Customer Service
• Cross platform functionality with mobile responsive navigation
“The intent of the project was two-fold. First, as the largest provider of hemodialysis water equipment in North America, we wanted to have a catalog that provided products specific to those hemodialysis water users and providers. Second, we wanted to improve the experience of finding product and pricing information by presenting a more interactive and easy to use tool” said Chris Fournier, VP Marketing.
Hard copies of the new Dialysis Water Product Catalog can be requested by by calling Mar Cor Customer Service at 800.633.3080. Visit catalog.mcpur.com today to check out the all new Mar Cor Purification Dialysis Water Digital Catalog, and keep up-to-date with exiting new dialysis products and services designed to ensure safe water and improve provider productivity.
About Cantel Medical
Cantel Medical (NYS: CMN) - Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, and hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com .
About Mar Cor Purification
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including nine ion exchange resin regeneration plants strategically located in large metropolitan areas. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network. Visit our website at mcpur.com to find out more about Mar Cor Purification.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE: Mar Cor Purification.
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Jan. 14, 2016 [format] => [safe_value] => Jan. 14, 2016 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [description] => Array ( [value] => Designed to improve customer experience by providing faster access ) [keywords] => Array ( [value] => dialysis water, hemodialysis water, dialysis water products, hemodialysis water products ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454534627 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [4] => stdClass Object ( [vid] => 204 [uid] => 33 [title] => Mar Cor Purification Employee Participation in Kidney Walks Helps Raise $16,471 for the National Kidney Foundation [log] => [status] => 1 [comment] => 2 [promote] => 1 [sticky] => 0 [nid] => 204 [type] => news_and_events [language] => und [created] => 1454534978 [changed] => 1457977455 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1457977455 [revision_uid] => 36 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>Each Year, the National Kidney Foundation’s Kidney Walks, with than 75,000 walkers, raise over $8 million to help kidney patients and their families. For the 10th year in a row Mar Cor Purification has formed a team to participate in the walk and raise money for the charity. This year Mar Cor Purification formed two teams each located near Mar Cor Purification office locations in Plymouth, Minnesota and Skippack, Pennsylvania and raised a combined $16,471.
On October 10, 2015, group of 30 Mar Cor employees participated in the 2015 Twin Cities Kidney Walk and raised $7,620. Following the success of the Twin Cities Walk, on October 24, 2015 a larger group of 61 Mar Cor employees participated in the 2015 Chester County Kidney Walk and raised $8,851. Mar Cor Purification, a leading provider of Dialysis Water Treatment and a frequent contributor to the National Kidney Foundation and their commitment to “the awareness, prevention and treatment of kidney disease”.
For more information on upcoming NKF Kidney Walks, visit NKF Kidney Walk website or the National Kidney Foundation website at www.kidney.org. |  |
|
Each Year, the National Kidney Foundation’s Kidney Walks, with than 75,000 walkers, raise over $8 million to help kidney patients and their families. For the 10th year in a row Mar Cor Purification has formed a team to participate in the walk and raise money for the charity. This year Mar Cor Purification formed two teams each located near Mar Cor Purification office locations in Plymouth, Minnesota and Skippack, Pennsylvania and raised a combined $16,471.
On October 10, 2015, group of 30 Mar Cor employees participated in the 2015 Twin Cities Kidney Walk and raised $7,620. Following the success of the Twin Cities Walk, on October 24, 2015 a larger group of 61 Mar Cor employees participated in the 2015 Chester County Kidney Walk and raised $8,851. Mar Cor Purification, a leading provider of Dialysis Water Treatment and a frequent contributor to the National Kidney Foundation and their commitment to “the awareness, prevention and treatment of kidney disease”.
For more information on upcoming NKF Kidney Walks, visit NKF Kidney Walk website or the National Kidney Foundation website at www.kidney.org. |
|
Multiple ports aid dialysis clinic personnel in pretreatment testing.
Mar Cor aims to provide solutions to clinics’ everyday issues, making daily tasks more efficient and easier to manage. Released in 2104, and built for convenience, the lightweight, multi-port PTS-47 Pretreatment Testing Station provides welcome relief to clinic personnel whose jobs entail the sampling of pretreatment water from multiple devices. The centralized testing station puts all testing ports in one, centralized, convenient package.
The PTS-47 routes all water samples to one point, allowing for easier and less time consuming testing protocols. Sample ports, which have been historically found after each required pretreatment device are now routed directly to the PTS-47, eliminating the hassle of dealing with multiple devices at once. This removes tight spaces between pretreatment devices, making collection of these samples easier.
Four sample polyvinylchloride valves are included, but with the capacity for seven, the clinic can add more if desired. The PTS-47 provides additional value as it can significantly improve rinse-time capability, enhancing sampling techniques. Keeping personnel and equipment dry during testing is always a challenging, and the PTS-47 addresses these issues by providing the user a large (1-7/16” opening) plastic drain keeps floors dry.
The PTS-47 is built to make the tasking of pretreatment sampling as simple and efficient as possible with ports and valves that are descriptively labeled and color-coded for quality assurance. Weighing in at five pounds, with dimensions of 12” x 15” x 6”, the compact, lightweight PTS-47 is simple to position and quick easy to install.
Response to the PTS-47 has been overwhelmingly positive both into brand new system installations and into existing water systems. Mar Cor will continue to search for ways to improve provider productivity and ensure patient safety.
More InformationPTS-47Pretreatment Testing Station The PTS-47 is a Pretreatment Testing Station specifically designed for hemodialysis water treatment systems. It serves as a collection site for the express purpose of analyzing incoming water conditions. It holds four (4) sample valves with the capacity for seven (7) thereby allowing clinical personnel to collect all require feed water tests from one location. Sample ports that are normally found after each required pretreatment device are now routed directly to the PTS-47. |  | ||
Multiple ports aid dialysis clinic personnel in pretreatment testing.
Mar Cor aims to provide solutions to clinics’ everyday issues, making daily tasks more efficient and easier to manage. Released in 2104, and built for convenience, the lightweight, multi-port PTS-47 Pretreatment Testing Station provides welcome relief to clinic personnel whose jobs entail the sampling of pretreatment water from multiple devices. The centralized testing station puts all testing ports in one, centralized, convenient package.
The PTS-47 routes all water samples to one point, allowing for easier and less time consuming testing protocols. Sample ports, which have been historically found after each required pretreatment device are now routed directly to the PTS-47, eliminating the hassle of dealing with multiple devices at once. This removes tight spaces between pretreatment devices, making collection of these samples easier.
Four sample polyvinylchloride valves are included, but with the capacity for seven, the clinic can add more if desired. The PTS-47 provides additional value as it can significantly improve rinse-time capability, enhancing sampling techniques. Keeping personnel and equipment dry during testing is always a challenging, and the PTS-47 addresses these issues by providing the user a large (1-7/16” opening) plastic drain keeps floors dry.
The PTS-47 is built to make the tasking of pretreatment sampling as simple and efficient as possible with ports and valves that are descriptively labeled and color-coded for quality assurance. Weighing in at five pounds, with dimensions of 12” x 15” x 6”, the compact, lightweight PTS-47 is simple to position and quick easy to install.
Response to the PTS-47 has been overwhelmingly positive both into brand new system installations and into existing water systems. Mar Cor will continue to search for ways to improve provider productivity and ensure patient safety.
More InformationPTS-47Pretreatment Testing Station The PTS-47 is a Pretreatment Testing Station specifically designed for hemodialysis water treatment systems. It serves as a collection site for the express purpose of analyzing incoming water conditions. It holds four (4) sample valves with the capacity for seven (7) thereby allowing clinical personnel to collect all require feed water tests from one location. Sample ports that are normally found after each required pretreatment device are now routed directly to the PTS-47. |
|
||
| DaVita Village Trust - Bridge of Life, and organization whose mission is to improve community health, wellness and vitality including chronic kidney disease education, prevention and treatment, recently highlighted Mar Cor Purification as a donor to the program. In 2014, DaVita Village Trust (DVT) brought together two prominent kidney care non-profit organizations. The combined programs of The Kidney TRUST and Bridge of Life (BOL) allow DaVita Village Trust to provide a full range of kidney care services. These include international medical missions that deliver dialysis treatment and pimary care service to patients who would otherwise not receive care and free-rapid screening programs to identify those who have signs of kidney impairment within the United States and abroad.In 2015, Bridge of Life became the primary program of DVT and serves thousands of men, women and children through four impact areas: kidney care, primary care, education and prevention, and medically supported camps for kids. |  | |
Mar Cor Purification is proud to be a donor to a program, "Mar Cor has always believed in giving back to the community. BOL has given us an amazing opportunity to support them while they are driving an incredible initiative to save lives that would otherwise be lost. Giving financial support to this cause was a no-brainer for Mar Cor Purification, and we truly appreciate the opportunity." - Rich Benner, Senior Manager, Strategic Accounts.
To read the entire Donor Spotlight click here
For more information on the DaVita Village Trust - Bridge of Life Program visit their website, or visit their online donation form to make a donation. | ||
| DaVita Village Trust - Bridge of Life, and organization whose mission is to improve community health, wellness and vitality including chronic kidney disease education, prevention and treatment, recently highlighted Mar Cor Purification as a donor to the program. In 2014, DaVita Village Trust (DVT) brought together two prominent kidney care non-profit organizations. The combined programs of The Kidney TRUST and Bridge of Life (BOL) allow DaVita Village Trust to provide a full range of kidney care services. These include international medical missions that deliver dialysis treatment and pimary care service to patients who would otherwise not receive care and free-rapid screening programs to identify those who have signs of kidney impairment within the United States and abroad.In 2015, Bridge of Life became the primary program of DVT and serves thousands of men, women and children through four impact areas: kidney care, primary care, education and prevention, and medically supported camps for kids. | |
|
|
Mar Cor Purification is proud to be a donor to a program, "Mar Cor has always believed in giving back to the community. BOL has given us an amazing opportunity to support them while they are driving an incredible initiative to save lives that would otherwise be lost. Giving financial support to this cause was a no-brainer for Mar Cor Purification, and we truly appreciate the opportunity." - Rich Benner, Senior Manager, Strategic Accounts.
To read the entire Donor Spotlight click here
For more information on the DaVita Village Trust - Bridge of Life Program visit their website, or visit their online donation form to make a donation. |
||
The Life Sciences water market, unique for the wide range of applications and market conditions, particularly start-up pharmaceutical, lab water makeup, and cosmetics, has historically required the use of custom water systems to meet the varied needs of the end users.
With exacting standards, wide range of flow rates, and numerous optional components, Mar Cor’s 4400L high purity water system aims to standardize this notoriously unpredictable market. The standard, low cost system that includes many popular optional components and is capable of meeting the needs of almost any high purity water applications.
The 4400L Product Introduction Video
More Information4400L™ High Purity Water System2,800 to 11,000 GPD Generation & 28,800 to 115,200 GPD Storage & Delivery The 4400L is designed to produce up to 8 US gpm (30 lpm) at 41°F (5°C) of pure water to a storage and delivery system that can pump up to 80 US gpm (303 lpm) of high quality water to various points of use. The color touch HMI view coupled with an industrial PLC provides a robust control system for operator ease of use. |  | ||
The Life Sciences water market, unique for the wide range of applications and market conditions, particularly start-up pharmaceutical, lab water makeup, and cosmetics, has historically required the use of custom water systems to meet the varied needs of the end users.
With exacting standards, wide range of flow rates, and numerous optional components, Mar Cor’s 4400L high purity water system aims to standardize this notoriously unpredictable market. The standard, low cost system that includes many popular optional components and is capable of meeting the needs of almost any high purity water applications.
The 4400L Product Introduction Video
More Information4400L™ High Purity Water System2,800 to 11,000 GPD Generation & 28,800 to 115,200 GPD Storage & Delivery The 4400L is designed to produce up to 8 US gpm (30 lpm) at 41°F (5°C) of pure water to a storage and delivery system that can pump up to 80 US gpm (303 lpm) of high quality water to various points of use. The color touch HMI view coupled with an industrial PLC provides a robust control system for operator ease of use. |
|
||
The National Association of Nephrology Technicians/Technologists (NANT) partnered with Mar Cor Purification to launch the first new book about water for dialysis since the Water Treatment Manual was published by the FDA in 1989. Seventeen authors representing key water treatment professionals, dialysis professionals and academicians contributed their expertise to bring this much needed information to the dialysis community.
The 209-page manual features twelve chapters, including source water, risks and hazards of dialysis water, design of water treatment systems, pre-treatment equipment, primary treatment devices, water distribution, monitoring, and system maintenance. It also covers portable water treatment systems for acute and home dialysis as well as water quality standards and regulations. Seven appendices include a sample letter to a water supplier, ANSI/AAMI maximum contaminant levels, EPA primary drinking water contaminant list, water related V-Tags from CMS Conditions of Coverage and a sample home hemodialysis environmental survey.
Curt Weitnauer, President of Mar Cor Purification, stated “The release of this new NANT publication is an integral step in educating the hemodialysis community both on the importance of water quality and on the effective management of all water generating processes and components. Mar Cor is pleased to have had the opportunity to be involved in the development of a manual that will go a long way to increase hemodialysis provider knowledge and ultimately impact long term patient safety.”
The book is available in both printed softbound and electronic versions from NATIONAL ASSOCIATION OF NEPHROLOGY TECHNICIANS website.
[summary] => [format] => full_html [safe_value] =>
The National Association of Nephrology Technicians/Technologists (NANT) partnered with Mar Cor Purification to launch the first new book about water for dialysis since the Water Treatment Manual was published by the FDA in 1989. Seventeen authors representing key water treatment professionals, dialysis professionals and academicians contributed their expertise to bring this much needed information to the dialysis community.
The 209-page manual features twelve chapters, including source water, risks and hazards of dialysis water, design of water treatment systems, pre-treatment equipment, primary treatment devices, water distribution, monitoring, and system maintenance. It also covers portable water treatment systems for acute and home dialysis as well as water quality standards and regulations. Seven appendices include a sample letter to a water supplier, ANSI/AAMI maximum contaminant levels, EPA primary drinking water contaminant list, water related V-Tags from CMS Conditions of Coverage and a sample home hemodialysis environmental survey.
Curt Weitnauer, President of Mar Cor Purification, stated “The release of this new NANT publication is an integral step in educating the hemodialysis community both on the importance of water quality and on the effective management of all water generating processes and components. Mar Cor is pleased to have had the opportunity to be involved in the development of a manual that will go a long way to increase hemodialysis provider knowledge and ultimately impact long term patient safety.”
The book is available in both printed softbound and electronic versions from NATIONAL ASSOCIATION OF NEPHROLOGY TECHNICIANS website.
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Apr. 2, 2015 [format] => [safe_value] => Apr. 2, 2015 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [description] => Array ( [value] => The National Association of Nephrology Technicians/Technologists (NANT) partnered with Mar Cor Purification to launch the first new book about water for dialysis since the Water Treatment Manual was published by the FDA in 1989 ) [keywords] => Array ( [value] => dialysis, dialysis water, dialsyis water treatment ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454535775 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [9] => stdClass Object ( [vid] => 209 [uid] => 33 [title] => New Video Highlights Features that make the Minncare Dry Fog 2 System a Vital Component in Cleanroom Bio-Decontamination [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 209 [type] => news_and_events [language] => und [created] => 1454535878 [changed] => 1457978038 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1457978038 [revision_uid] => 36 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>
Now a commonplace technology as part of modern cleanroom disinfection procedures, the Minncare Dry Fog System has established itself as an effective and trusted component in routine disinfection protocol. The established clean room decontamination technology has been in place for over ten years and is currently in use in hundreds of clean rooms worldwide. The vaporization technology employed by the system make it one of the most advanced and effective clean room bio-decontamination technologies available. The system delivers a vaporized form of Minncare, a peracetic acid based sterilant, that acts as an oxidizer to destroy a microbial organism’s structure. These Dry Fog droplets are so fine that they ensure even dispersion of chemical sterilant, reducing the risk of corrosion and condensation in a clean room. Additionally, while other disinfection procedures can take up to 3-5 days to complete, the Dry Fog technology can assist in dramatically reducing this time. In conjunction with your normal cleanroom disinfection procedures the Minncare Dry For 2 System typically takes 3 hours. The mobility of the system means it can be used almost anywhere—hospitals, laboratories, businesses—in addition to clean-room applications.
Looking to improve the overall user experience of the Dry Fog system, Mar Cor recently finished development of the next generation of Dry Fog technology. The result of this endeavor, the Minncare Dry Fog 2 System, has enhancements that improve the durability and flexibility of the system compared to its original counterpart. The improved spray head has eight different nozzle ports, capable of pointing both horizontally and vertically. This flexibility allows the system to more accurately direct vapors in complex clean room environments. The updated stainless steel design, including a completely stainless steel head, ensures the system’s longevity, warding off corrosion and making the system virtually maintenance free. These enhancements effectively lower labor and operating costs involved in the on-going decontamination of a clean room.
This improved design has Mar Cor excited to share this new technology with clean room operators worldwide. These same operators should in turn be exited, as the new Minncare Dry Fog 2 System is a sound investment for any facility in need of critical area fogging. For more information on the Dry Fog 2 see this informative data sheet or this introduction video which provides an in depth overview of the system operation. Contact Mar Cor Purification for more information and to experience this vital technology for your clean room and the benefits it provides yourself.
The Minncare Dry Fog 2 Product Introduction Video
More InformationMinncare Dry Fog 2 SystemClean Room Aerosol-Based Bio-Decontamination The Minncare Dry Fog 2 system provides an easy to use, high technology solution for clean room and critical area fogging. The combination of our highly effective Minncare Cold Sterilant chemical and our state of the art Dry Fog delivery system enables users to rapidly and safely deliver Minncare vapor to even the most complex areas. Its sanitary and autoclavable design will permit its use in the most critical areas within pharmaceutical and other industries concerned with maintaining the utmost levels of sterility. |  | ||
Now a commonplace technology as part of modern cleanroom disinfection procedures, the Minncare Dry Fog System has established itself as an effective and trusted component in routine disinfection protocol. The established clean room decontamination technology has been in place for over ten years and is currently in use in hundreds of clean rooms worldwide. The vaporization technology employed by the system make it one of the most advanced and effective clean room bio-decontamination technologies available. The system delivers a vaporized form of Minncare, a peracetic acid based sterilant, that acts as an oxidizer to destroy a microbial organism’s structure. These Dry Fog droplets are so fine that they ensure even dispersion of chemical sterilant, reducing the risk of corrosion and condensation in a clean room. Additionally, while other disinfection procedures can take up to 3-5 days to complete, the Dry Fog technology can assist in dramatically reducing this time. In conjunction with your normal cleanroom disinfection procedures the Minncare Dry For 2 System typically takes 3 hours. The mobility of the system means it can be used almost anywhere—hospitals, laboratories, businesses—in addition to clean-room applications.
Looking to improve the overall user experience of the Dry Fog system, Mar Cor recently finished development of the next generation of Dry Fog technology. The result of this endeavor, the Minncare Dry Fog 2 System, has enhancements that improve the durability and flexibility of the system compared to its original counterpart. The improved spray head has eight different nozzle ports, capable of pointing both horizontally and vertically. This flexibility allows the system to more accurately direct vapors in complex clean room environments. The updated stainless steel design, including a completely stainless steel head, ensures the system’s longevity, warding off corrosion and making the system virtually maintenance free. These enhancements effectively lower labor and operating costs involved in the on-going decontamination of a clean room.
This improved design has Mar Cor excited to share this new technology with clean room operators worldwide. These same operators should in turn be exited, as the new Minncare Dry Fog 2 System is a sound investment for any facility in need of critical area fogging. For more information on the Dry Fog 2 see this informative data sheet or this introduction video which provides an in depth overview of the system operation. Contact Mar Cor Purification for more information and to experience this vital technology for your clean room and the benefits it provides yourself.
The Minncare Dry Fog 2 Product Introduction Video
More InformationMinncare Dry Fog 2 SystemClean Room Aerosol-Based Bio-Decontamination The Minncare Dry Fog 2 system provides an easy to use, high technology solution for clean room and critical area fogging. The combination of our highly effective Minncare Cold Sterilant chemical and our state of the art Dry Fog delivery system enables users to rapidly and safely deliver Minncare vapor to even the most complex areas. Its sanitary and autoclavable design will permit its use in the most critical areas within pharmaceutical and other industries concerned with maintaining the utmost levels of sterility. |
|
||
The Millenium 750 was first introduced back in the early 2000s as a Class II medical device and for many years it has been the leading portable RO machine in the industry. With its compact size, unique feature set, consistent water quality production, and dependable operation, the Millenium has proven itself reliable for assisting in both acute and home hemodialysis treatment settings. Mar Cor estimates that over 10,000 units were sold. However with the rise of heat disinfection technology, demand for the product has declined and the product will be retired.
|  |
|
The Millenium 750 was first introduced back in the early 2000s as a Class II medical device and for many years it has been the leading portable RO machine in the industry. With its compact size, unique feature set, consistent water quality production, and dependable operation, the Millenium has proven itself reliable for assisting in both acute and home hemodialysis treatment settings. Mar Cor estimates that over 10,000 units were sold. However with the rise of heat disinfection technology, demand for the product has declined and the product will be retired. Owners of the Millenium can continue to operate this machine without issue by following recommended manufacturer’s policies and procedures all in accordance with AAMI standards. Mar Cor will continue to support the Millenium 750 RO by offering spare parts, supplies, technical, and field service for the next seven years once the official discontinued date has been established later this year. Mar Cor continues to offer a variety of portable RO machines for this application including the hot water disinfectable WRO 3O0 H and the Millenium HX units. If you have any questions, please contact us at 800-633-3080.
|
|
Durable Stainless Steel Construction and Redesigned Delivery System Streamline Decontamination Procedures and Reduce Cleanroom Downtime
Plymouth, MN – February 3, 2015 - Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE:CMN) has launched a new aerosol-based bio-decontamination system, the MINNCARE DRY FOG® 2, the latest evolution of Mar Cor’s Dry Fog Technology and an integral part of modern clean room disinfection procedures. Aimed specifically at the cleanroom industry, the new and improved system is designed completely of 316 L stainless steel and features a robust construction that is engineered to be durable and virtually maintenance free. The new design also features a multi-directional spray apparatus that allows for eight different nozzle(s) positions increasing the coverage possibilities for higher flexibility.
Christopher Fournier, VP Marketing, noted, “The new system delivers many new features that increase the coverage and flexibility of our dry fog technology. The redesigned distribution mechanism allows for spray diffusion that is horizontal or vertical, while linking capability permits decontamination of multiple linked rooms simultaneously. These features come with the 100% autoclavable design, short process time, and optimal efficacy that has historically been associated with Dry Fog Technology and MINNCARE® Cold Sterilant. These improvements will allow the end user to improve the efficiency of their clean room disinfection procedures, utilizing the Dry Fog 2 system in conjunction with traditional disinfection procedures.” MINNCARE® and MINNCARE DRY FOG® are registered trademarks of Medivators Inc. (a Cantel Medical Company)
MINNCARE® is a registered trademark of Medivators Inc. (a Cantel Medical Company)
About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc.,a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including nine ion exchange resin regeneration plants strategically located in large metropolitan areas. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE: Mar Cor Purification
[summary] => [format] => full_html [safe_value] =>
Durable Stainless Steel Construction and Redesigned Delivery System Streamline Decontamination Procedures and Reduce Cleanroom Downtime
Plymouth, MN – February 3, 2015 - Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE:CMN) has launched a new aerosol-based bio-decontamination system, the MINNCARE DRY FOG® 2, the latest evolution of Mar Cor’s Dry Fog Technology and an integral part of modern clean room disinfection procedures. Aimed specifically at the cleanroom industry, the new and improved system is designed completely of 316 L stainless steel and features a robust construction that is engineered to be durable and virtually maintenance free. The new design also features a multi-directional spray apparatus that allows for eight different nozzle(s) positions increasing the coverage possibilities for higher flexibility.
Christopher Fournier, VP Marketing, noted, “The new system delivers many new features that increase the coverage and flexibility of our dry fog technology. The redesigned distribution mechanism allows for spray diffusion that is horizontal or vertical, while linking capability permits decontamination of multiple linked rooms simultaneously. These features come with the 100% autoclavable design, short process time, and optimal efficacy that has historically been associated with Dry Fog Technology and MINNCARE® Cold Sterilant. These improvements will allow the end user to improve the efficiency of their clean room disinfection procedures, utilizing the Dry Fog 2 system in conjunction with traditional disinfection procedures.” MINNCARE® and MINNCARE DRY FOG® are registered trademarks of Medivators Inc. (a Cantel Medical Company)
MINNCARE® is a registered trademark of Medivators Inc. (a Cantel Medical Company)
About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc.,a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including nine ion exchange resin regeneration plants strategically located in large metropolitan areas. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE: Mar Cor Purification
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Feb. 4, 2015 [format] => [safe_value] => Feb. 4, 2015 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [description] => Array ( [value] => Durable stainless steel sonstruction and redesigned delivery system streamline cleanroom decontamination procedures and reduce cleanroom downtime ) [keywords] => Array ( [value] => cleanroom disinfection, cleanroom biodecontamination, clean room disinfection ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454536068 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [12] => stdClass Object ( [vid] => 213 [uid] => 33 [title] => Mar Cor Purification Given 510(K) Clearance for Minncare® HD Disinfectant for Use in Water System Disinfection in Kidney Dialysis Applications [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 213 [type] => news_and_events [language] => und [created] => 1454536202 [changed] => 1457977332 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1457977332 [revision_uid] => 36 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>
First Disinfectant Cleared by FDA for Water System Disinfection in Hemodialysis
Little Falls, N.J. January 15, 2015 - Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE:CMN) announced today that it has been given 510(k) clearance (K133724) from the FDA for MINNCARE® HD high level disinfectant, the first water system disinfectant granted a medical device clearance for use in hemodialysis applications. MINNCARE HD disinfectant is a proprietary blend of peracetic acid and hydrogen peroxide and is completely biodegradable allowing for easy disposal and reducing environmental impact. The non-medical device version, MINNCARE® Cold Sterilant, is considered the gold standard in water system disinfection and is used daily in a variety of markets and applications.
MINNCARE HD disinfectant was developed to address the critical need for a validated water system disinfectant that is both safe and effective. After developing an effective protocol with the FDA, Mar Cor successfully conducted extensive testing to validate product performance and safety. Together with MINNCARE HD disinfectant, Mar Cor will offer validated test strips for testing strength and to verify that there are no residuals following a disinfection procedure. Both products will be available in early February 2015.
John Rickert, VP Medical Sales, noted, "MINNCARE HD disinfectant eliminates the risk of using unregulated industrial chemicals, such as chlorine bleach, in patient treatment areas. The disinfection protocol is validated, the chemistry has been proven efficacious, and accurate test strips are available to insure dosage, as well as to verify complete rinse-out of the disinfectant. The use of MINNCARE HD disinfectant in a dialysis clinic will help maintain the water system in optimum condition and make it easier for the water system operator to complete an effective disinfection."
MINNCARE® is a registered trademark of Medivators Inc. (a Cantel Medical Company)
About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-subsidiary-mar-cor-purification-given-510k-clearance-for-minncare-hd-disinfectant-for-use-in-water-system-disinfection-in-kidney-dialysis-applications-300021524
SOURCE Cantel Medical Corp.
[summary] => [format] => full_html [safe_value] =>
First Disinfectant Cleared by FDA for Water System Disinfection in Hemodialysis
Little Falls, N.J. January 15, 2015 - Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE:CMN) announced today that it has been given 510(k) clearance (K133724) from the FDA for MINNCARE® HD high level disinfectant, the first water system disinfectant granted a medical device clearance for use in hemodialysis applications. MINNCARE HD disinfectant is a proprietary blend of peracetic acid and hydrogen peroxide and is completely biodegradable allowing for easy disposal and reducing environmental impact. The non-medical device version, MINNCARE® Cold Sterilant, is considered the gold standard in water system disinfection and is used daily in a variety of markets and applications.
MINNCARE HD disinfectant was developed to address the critical need for a validated water system disinfectant that is both safe and effective. After developing an effective protocol with the FDA, Mar Cor successfully conducted extensive testing to validate product performance and safety. Together with MINNCARE HD disinfectant, Mar Cor will offer validated test strips for testing strength and to verify that there are no residuals following a disinfection procedure. Both products will be available in early February 2015.
John Rickert, VP Medical Sales, noted, "MINNCARE HD disinfectant eliminates the risk of using unregulated industrial chemicals, such as chlorine bleach, in patient treatment areas. The disinfection protocol is validated, the chemistry has been proven efficacious, and accurate test strips are available to insure dosage, as well as to verify complete rinse-out of the disinfectant. The use of MINNCARE HD disinfectant in a dialysis clinic will help maintain the water system in optimum condition and make it easier for the water system operator to complete an effective disinfection."
MINNCARE® is a registered trademark of Medivators Inc. (a Cantel Medical Company)
About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-subsidiary-mar-cor-purification-given-510k-clearance-for-minncare-hd-disinfectant-for-use-in-water-system-disinfection-in-kidney-dialysis-applications-300021524
SOURCE Cantel Medical Corp.
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Jan. 15, 2015 [format] => [safe_value] => Jan. 15, 2015 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 176 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_13.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454541184 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://www.prnewswire.com/news-releases/cantel-medical-subsidiary-mar-cor-purification-given-510k-clearance-for-minncare-hd-disinfectant-for-use-in-water-system-disinfection-in-kidney-dialysis-applications-300021524 [format] => [safe_value] => http://www.prnewswire.com/news-releases/cantel-medical-subsidiary-mar-cor-purification-given-510k-clearance-for-minncare-hd-disinfectant-for-use-in-water-system-disinfection-in-kidney-dialysis-applications-300021524 ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [description] => Array ( [value] => Minncare HD Disinfectant is the First Disinfectant Cleared by FDA for Water System Disinfection in Hemodialysis ) [keywords] => Array ( [value] => 510(k) disinfectant, 510k disinfectant, 510(k) water system ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454536202 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [13] => stdClass Object ( [vid] => 215 [uid] => 33 [title] => Mar Cor Purification Releases 2015 MCP US Medical Product Price Guide [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 215 [type] => news_and_events [language] => und [created] => 1454536449 [changed] => 1455120076 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455120076 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Jan. 5, 2015 [format] => [safe_value] => Jan. 5, 2015 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://catalog.mcpur.com/app.php?RelId=6.7.0.10.16 [format] => [safe_value] => http://catalog.mcpur.com/app.php?RelId=6.7.0.10.16 ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454536449 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [14] => stdClass Object ( [vid] => 216 [uid] => 33 [title] => Cantel Medical Acquires Pure Water Solutions, Inc. [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 216 [type] => news_and_events [language] => und [created] => 1454536946 [changed] => 1457977554 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1457977554 [revision_uid] => 36 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>
FURTHER ENHANCING ITS NATIONAL WATER PURIFICATION AND FILTRATION GEOGRAPHIC FOOTPRINT IN THE SOUTHEASTERN UNITED STATES
Little Falls, N.J. January 2, 2015 - CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired the assets of Pure Water Solutions, Inc. for a purchase price of $11.9 million in cash consideration. Headquartered in Ridgeland, Mississippi, Pure Water Solutions provides water purification and treatment services for commercial and industrial, laboratory and medical customers out of eight regional offices throughout the Southeastern United States. The company had pre-acquisition unaudited revenues and EBITDA of just over $8 million and $2 million, respectively, for the trailing twelve months. This transaction is expected to be neutral to Cantel's GAAP EPS in FY15 and slightly accretive to its non-GAAP1 EPS in FY15, and is expected to be accretive on both a GAAP and non-GAAP[1] basis thereafter.
Curtis Weitnauer, President and CEO of Mar Cor Purification, stated, "Adding the Pure Water Solutions business and its strategic Southeastern US market presence to our leadership position in life sciences water purification and filtration enables us to better serve our national customers and further expand our commercial and industrial segments. We expect to drive incremental growth with the addition of Mar Cor Purification's capabilities and broad portfolio of products and services."
Rob Simmons, Chief Executive Officer of Pure Water Solutions, will continue as an employee of Mar Cor Purification, where he will assist in the integration and continued service of the Pure Water Solutions customer base and the growth of the broader commercial and industrial water business.
About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 27 cities in the United States and Canada including seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.
About Pure Water Solutions
Pure Water Solutions has been providing High Purity Water Treatment Systems throughout most of the Southern United States since 1969. The Company was founded by Dr. John D. Bower to ensure high water quality for hemodialysis patients in Mississippi. Over the years the company has grown to meet the increasing demand for hemodialysis services in theSoutheast United States. Under the leadership of John M. Bower and subsequently Rob Simmons as CEO, the company has expanded to meet the needs of commercial and industrial customers in the region. Pure Water Solutions customers range from large industrial companies with complex ultrapure water treatment needs to those with simple deionized water applications. Pure Water Solutions has an extensive network of regional offices with trained sales and service professionals.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
[1] Non-GAAP EPS represents Earnings Per Share excluding acquisition-related intangible amortization as well as transaction-related expenses. For further disclosure regarding non-GAAP items please refer to Cantel Medical's latest quarterly filing.
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/cantel-medical-acquires-pure-water-solutions-inc-300014913 SOURCE Cantel Medical Corp.
[summary] => [format] => full_html [safe_value] =>FURTHER ENHANCING ITS NATIONAL WATER PURIFICATION AND FILTRATION GEOGRAPHIC FOOTPRINT IN THE SOUTHEASTERN UNITED STATES
Little Falls, N.J. January 2, 2015 - CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired the assets of Pure Water Solutions, Inc. for a purchase price of $11.9 million in cash consideration. Headquartered in Ridgeland, Mississippi, Pure Water Solutions provides water purification and treatment services for commercial and industrial, laboratory and medical customers out of eight regional offices throughout the Southeastern United States. The company had pre-acquisition unaudited revenues and EBITDA of just over $8 million and $2 million, respectively, for the trailing twelve months. This transaction is expected to be neutral to Cantel's GAAP EPS in FY15 and slightly accretive to its non-GAAP1 EPS in FY15, and is expected to be accretive on both a GAAP and non-GAAP[1] basis thereafter.
Curtis Weitnauer, President and CEO of Mar Cor Purification, stated, "Adding the Pure Water Solutions business and its strategic Southeastern US market presence to our leadership position in life sciences water purification and filtration enables us to better serve our national customers and further expand our commercial and industrial segments. We expect to drive incremental growth with the addition of Mar Cor Purification's capabilities and broad portfolio of products and services."
Rob Simmons, Chief Executive Officer of Pure Water Solutions, will continue as an employee of Mar Cor Purification, where he will assist in the integration and continued service of the Pure Water Solutions customer base and the growth of the broader commercial and industrial water business.
About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 27 cities in the United States and Canada including seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.
About Pure Water Solutions
Pure Water Solutions has been providing High Purity Water Treatment Systems throughout most of the Southern United States since 1969. The Company was founded by Dr. John D. Bower to ensure high water quality for hemodialysis patients in Mississippi. Over the years the company has grown to meet the increasing demand for hemodialysis services in theSoutheast United States. Under the leadership of John M. Bower and subsequently Rob Simmons as CEO, the company has expanded to meet the needs of commercial and industrial customers in the region. Pure Water Solutions customers range from large industrial companies with complex ultrapure water treatment needs to those with simple deionized water applications. Pure Water Solutions has an extensive network of regional offices with trained sales and service professionals.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
[1] Non-GAAP EPS represents Earnings Per Share excluding acquisition-related intangible amortization as well as transaction-related expenses. For further disclosure regarding non-GAAP items please refer to Cantel Medical's latest quarterly filing.
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/cantel-medical-acquires-pure-water-solutions-inc-300014913 SOURCE Cantel Medical Corp.
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Jan. 2, 2015 [format] => [safe_value] => Jan. 2, 2015 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 161 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_0.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454536946 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://investor.shareholder.com/CNTL/releasedetail.cfm?ReleaseID=889250 [format] => [safe_value] => http://investor.shareholder.com/CNTL/releasedetail.cfm?ReleaseID=889250 ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [title] => Array ( [value] => [node:title] | Mar Cor Purification ) [description] => Array ( [value] => Adding the Pure Water Solutions business and its strategic Southeastern US market presence to our leadership position in life sciences water purification and filtration ) [keywords] => Array ( [value] => service deionization, service di ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454536946 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [15] => stdClass Object ( [vid] => 217 [uid] => 33 [title] => Cantel Medical Named to the Forbes 2014 List of the "100 Best Small Companies in America" [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 217 [type] => news_and_events [language] => und [created] => 1454537080 [changed] => 1456345142 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1456345142 [revision_uid] => 36 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Oct. 23, 2014 [format] => [safe_value] => Oct. 23, 2014 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://investor.shareholder.com/CNTL/releasedetail.cfm?ReleaseID=877797 [format] => [safe_value] => http://investor.shareholder.com/CNTL/releasedetail.cfm?ReleaseID=877797 ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [title] => Array ( [value] => [node:title] | Mar Cor Purification ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454537080 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [16] => stdClass Object ( [vid] => 218 [uid] => 33 [title] => PTG-520® Answers Dialysis Provider’s Call for a Lightweight, Cost-Effective Solution to Activated Carbon Tanks [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 218 [type] => news_and_events [language] => und [created] => 1454537221 [changed] => 1457978046 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1457978046 [revision_uid] => 36 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>Dialysis providers have yearned for an alternative filtration technique that eliminates hazardous chlorine prior to their Reverse Osmosis (RO) machine in a lighter, more easily maneuverable package. The existing design which incorporates large activated carbon tanks is heavy, cumbersome, and time consuming to replace. Mar Cor Purification investigated carbon block technology as a solution to this on-going problem and as a result created the PTG-520® portable Carbon Filtration System. This compact, lightweight package will effectively remove harmful chlorine and chloramines prior to the RO system, just as activated carbon tanks would. However, the cost-effective PTG-520 carbon block technology eliminates the burden of lugging around weighty, unwieldy activated carbon tanks.
The average activated carbon two-tank system can weigh upwards of more than 150 pounds. To effectively be transported, they must be placed on a cart. But this can be overwhelming and challenging to move a complete water treatment system weighing over 300 pounds, especially in a fast-paced environment, up and down hallway ramps, and on and off elevators. The PTG-520 system with carbon block technology solves this issue by weighing less than 50 pounds. The PTG-520 fits onto various portable RO carts, including all Mar Cor Purification models. This design allows carbon block filters to be attached to the cart, making the chlorine/chloramine an all-in-one removal system that is much easier to navigate. Just as important, the PTG-520 has been tested to meet carbon filtration usage in accordance to with today’s standards, ANSI/AAMI/ISO 23500, specifically Annex F & G for acute and home hemodialysis settings.
Carbon filtration is an essential process prior to the RO system as it adsorbs both chlorines and chloramines commonly found in incoming feed water. This removal process is required first and foremost to ensure patient safety. In addition, if not done properly or efficiently, RO membrane(s) can be permanently damaged, costing both time and money. In a worst-case scenario test, the PTG-520 system using carbon block technology performed equivalently to standard activated carbon tanks. The test involved the filtration of hard-to-remove chloramines with a maximum level of 3.0 ppm concentration and 1.0 ppm ppm chlorine concentration (EPA water regulations’ recommended levels) as performance indicators. The test ran until a breakthrough occurred or when 30,800 gallons of water were consumed with a feed of 3 .0 ppm chloramine. 30,800 gallons represents an estimated one hemodialysis treatment per day (338 gallons) for 3 months or 13 weeks. Testing was done in 600 seconds on/600 seconds off cycle to simulate a challenging on-off scenario for the carbon blocks. In this worst-case, purposely challenging scenario, 30,800 gallons were reached without any chloramine or chlorine breakthrough.
For the dialysis provider looking for a portable, more easily-maneuverable solution to heavy activated carbon tanks that is still competitive in cost-effectiveness, operational efficiency and does not compromise patient safety, the PTG-520 is an excellent alternative. For more information on Carbon Block Filtration Technology, see our Application Brief outlining The Use of Carbon Block Technology for Portable RO Dialysis Applications
| Full Application Brief The Use of Carbon Block Technology for Portable RO Dialysis Applications |  | ||
More InformationPTG-520®Compact Carbon Filtration for Portable Dialysis RO Systems The PTG-520 Carbon Filtration System is a new option that is available to owners of portable RO systems. It is lighter, has a lower profile and is cost effective. The carbon block filter has been tested to meet specific regulations pertaining to the use of carbon as detailed in ANSI/AMMI/ISO 23500, specifically Annex F & G. |  |
Dialysis providers have yearned for an alternative filtration technique that eliminates hazardous chlorine prior to their Reverse Osmosis (RO) machine in a lighter, more easily maneuverable package. The existing design which incorporates large activated carbon tanks is heavy, cumbersome, and time consuming to replace. Mar Cor Purification investigated carbon block technology as a solution to this on-going problem and as a result created the PTG-520® portable Carbon Filtration System. This compact, lightweight package will effectively remove harmful chlorine and chloramines prior to the RO system, just as activated carbon tanks would. However, the cost-effective PTG-520 carbon block technology eliminates the burden of lugging around weighty, unwieldy activated carbon tanks.
The average activated carbon two-tank system can weigh upwards of more than 150 pounds. To effectively be transported, they must be placed on a cart. But this can be overwhelming and challenging to move a complete water treatment system weighing over 300 pounds, especially in a fast-paced environment, up and down hallway ramps, and on and off elevators. The PTG-520 system with carbon block technology solves this issue by weighing less than 50 pounds. The PTG-520 fits onto various portable RO carts, including all Mar Cor Purification models. This design allows carbon block filters to be attached to the cart, making the chlorine/chloramine an all-in-one removal system that is much easier to navigate. Just as important, the PTG-520 has been tested to meet carbon filtration usage in accordance to with today’s standards, ANSI/AAMI/ISO 23500, specifically Annex F & G for acute and home hemodialysis settings.
Carbon filtration is an essential process prior to the RO system as it adsorbs both chlorines and chloramines commonly found in incoming feed water. This removal process is required first and foremost to ensure patient safety. In addition, if not done properly or efficiently, RO membrane(s) can be permanently damaged, costing both time and money. In a worst-case scenario test, the PTG-520 system using carbon block technology performed equivalently to standard activated carbon tanks. The test involved the filtration of hard-to-remove chloramines with a maximum level of 3.0 ppm concentration and 1.0 ppm ppm chlorine concentration (EPA water regulations’ recommended levels) as performance indicators. The test ran until a breakthrough occurred or when 30,800 gallons of water were consumed with a feed of 3 .0 ppm chloramine. 30,800 gallons represents an estimated one hemodialysis treatment per day (338 gallons) for 3 months or 13 weeks. Testing was done in 600 seconds on/600 seconds off cycle to simulate a challenging on-off scenario for the carbon blocks. In this worst-case, purposely challenging scenario, 30,800 gallons were reached without any chloramine or chlorine breakthrough.
For the dialysis provider looking for a portable, more easily-maneuverable solution to heavy activated carbon tanks that is still competitive in cost-effectiveness, operational efficiency and does not compromise patient safety, the PTG-520 is an excellent alternative. For more information on Carbon Block Filtration Technology, see our Application Brief outlining The Use of Carbon Block Technology for Portable RO Dialysis Applications
| Full Application Brief The Use of Carbon Block Technology for Portable RO Dialysis Applications |
|
||
More InformationPTG-520®Compact Carbon Filtration for Portable Dialysis RO Systems The PTG-520 Carbon Filtration System is a new option that is available to owners of portable RO systems. It is lighter, has a lower profile and is cost effective. The carbon block filter has been tested to meet specific regulations pertaining to the use of carbon as detailed in ANSI/AMMI/ISO 23500, specifically Annex F & G. |
|
Mar Cor continually strives to develop innovative technologies designed to improve patient safety and increase provider productivity. Along those lines, Mar Cor's next generation central RO unit; the BioPure HX2 is a direct feed double pass reverse osmosis system and designed specially to meet stringent international hemodialysis water requirements. The BioPure HX2 double pass system ensures the highest water quality, while the added feature of automatic hot water disinfection simplifies bacteria control.
The BioPure HX2 is designed to meet AAMI grade water standards according to ANSI/AAMI 13959 and the equivalent CAN/CSA/ISO requirements. The system has a FDA 510(k) clearance and a Class III Device Licence in Canada. The system is equipped with 95% water recovery capability, offers high efficiency motors with variable frequency drives, and provides self-adjusting modulating valves to control reject flows. These standard energy and water saving features reduce on-going operating costs over the life of the system.
The BioPure HX2 joins an already diverse, and still growing, suite of products and systems for hemodialysis, following a trend of increasing innovation in RO technology and patient safety.
The BioPure HX2 Product Introduction Video can be viewed below
|
Mar Cor continually strives to develop innovative technologies designed to improve patient safety and increase provider productivity. Along those lines, Mar Cor's next generation central RO unit; the BioPure HX2 is a direct feed double pass reverse osmosis system and designed specially to meet stringent international hemodialysis water requirements. The BioPure HX2 double pass system ensures the highest water quality, while the added feature of automatic hot water disinfection simplifies bacteria control.
The BioPure HX2 is designed to meet AAMI grade water standards according to ANSI/AAMI 13959 and the equivalent CAN/CSA/ISO requirements. The system has a FDA 510(k) clearance and a Class III Device Licence in Canada. The system is equipped with 95% water recovery capability, offers high efficiency motors with variable frequency drives, and provides self-adjusting modulating valves to control reject flows. These standard energy and water saving features reduce on-going operating costs over the life of the system.
The BioPure HX2 joins an already diverse, and still growing, suite of products and systems for hemodialysis, following a trend of increasing innovation in RO technology and patient safety.
The BioPure HX2 Product Introduction Video can be viewed below
|
|
Mar Cor Purification continually strives to improve patient safety in the hemodialysis water industry with the latest innovations, using the most advanced technologies available. The removal of endotoxins, a well-known and difficult to remove the toxic substance that is bound to bacterial cell wall and released when the bacterium ruptures or disintegrates, is no different.
The Product Water Acceptance Criteria developed by CAN/CSA-ISO13959-11 and CAN/CSA-ISO11663-11 has defined two designations for the quality of product water, “Standard” and “Ultrapure”. It states the allowance for the “Standard” designation of endotoxin levels is less than 0.5 EU/ML. By contrast, allowance for “Ultrapure” is far more restrictive and must have less than 0.03 EU/ML, a huge improvement over the standard. Determined to exceed the “Standard” and even “Ultrapure” endotoxin levels, Mar Cor Purification developed the BioPure HX2 Double Pass Water Purification System. This next generation central RO unit for use in clinics and hospitals is intended to purify water for hemodialysis purposes and features built-in hot water disinfection that aids in the prevention and subsequent removal of bacteria and endotoxins all while reducing chemical dependence.
Utilizing a Limulus Amebocyte Lysate (LAL) test, Mar Cor Purification ran the BioPure HX2 ultrapure water system through a series of tests test aimed at identifying the endotoxin removal levels achievable using the double pass reverse osmosis process. The results of this study found that the BioPure HX2 was consistently achieving endotoxin levels of 0.01 EU/ML, exceeding Health Canada standards. This demonstrates the quality of water achievable utilizing the BioPure HX2 and highlights the potential patient safety benefits associated with consistently maintaining low levels of endotoxins. For more information on this test and a process flow diagram of Mar Cor Purification’s BioPure HX2, see the full research report below.
| Full Research Report |  | ||
More InformationBioPure HX2Double Pass Dialysis Water Purification System Mar Cor Purification offers the next generation central RO unit, the BioPure HX2. This direct feed double pass reverse osmosis system is designed specially to meet stringent international hemodialysis water requirements. |  |
Mar Cor Purification continually strives to improve patient safety in the hemodialysis water industry with the latest innovations, using the most advanced technologies available. The removal of endotoxins, a well-known and difficult to remove the toxic substance that is bound to bacterial cell wall and released when the bacterium ruptures or disintegrates, is no different.
The Product Water Acceptance Criteria developed by CAN/CSA-ISO13959-11 and CAN/CSA-ISO11663-11 has defined two designations for the quality of product water, “Standard” and “Ultrapure”. It states the allowance for the “Standard” designation of endotoxin levels is less than 0.5 EU/ML. By contrast, allowance for “Ultrapure” is far more restrictive and must have less than 0.03 EU/ML, a huge improvement over the standard. Determined to exceed the “Standard” and even “Ultrapure” endotoxin levels, Mar Cor Purification developed the BioPure HX2 Double Pass Water Purification System. This next generation central RO unit for use in clinics and hospitals is intended to purify water for hemodialysis purposes and features built-in hot water disinfection that aids in the prevention and subsequent removal of bacteria and endotoxins all while reducing chemical dependence.
Utilizing a Limulus Amebocyte Lysate (LAL) test, Mar Cor Purification ran the BioPure HX2 ultrapure water system through a series of tests test aimed at identifying the endotoxin removal levels achievable using the double pass reverse osmosis process. The results of this study found that the BioPure HX2 was consistently achieving endotoxin levels of 0.01 EU/ML, exceeding Health Canada standards. This demonstrates the quality of water achievable utilizing the BioPure HX2 and highlights the potential patient safety benefits associated with consistently maintaining low levels of endotoxins. For more information on this test and a process flow diagram of Mar Cor Purification’s BioPure HX2, see the full research report below.
| Full Research Report |
|
||
More InformationBioPure HX2Double Pass Dialysis Water Purification System Mar Cor Purification offers the next generation central RO unit, the BioPure HX2. This direct feed double pass reverse osmosis system is designed specially to meet stringent international hemodialysis water requirements. |
|
When other methods failed to meet their room disinfection standards, a large Midwest pharmaceutical plant selected the Minncare Dry Fog System, and it was up to the task. With the advances and innovations in the medical industry , the need for microbiological clean environments has been ever-increasing. Room disinfection and clean environments go hand-in-hand, and many microbiology sensitive industries rely solely on their clean rooms for production, research and development. With strict government regulations, customer liabilities and heavy competition a plant must have a quality disinfection process to continue innovating and producing.
The main reason was to eliminate formaldehyde and to have a faster process. Formaldye takes much longer to return to service because it is a hazardous chemical. The Midwest pharmaceutical plant was searching for a system that would increase automation, improve efficacy and achieve higher levels of reliability compared to their other systems, and decided to try critical area fogging—selecting the Minncare Dry Fog System. One DF system is capable of disinfecting rooms up to 35,000 cubic feet. With droplet sizes of only 7.5 microns, dry fogging droplets bounce off solid surfaces, eliminating excess condensation, the possibility of corrosion, and surface wetting, providing a cleaner, more thorough disinfection process than other fogging methods and manual spray-and-wipe.
The plant had already used two other disinfection procedures, H202 (hydrogen peroxide) and formaldehyde, but the methods left them unsatisfied. To see if the Minncare Dry Fog System was right for them, the plant conducted tests in the staging area for large parts and equipment about to be brought into the clean room, and also the active pharmaceutical ingredient production area, an area requiring exhaustive and thorough disinfection, which previously required the plant to be evacuated for days. The plant found the Dry Fog process to be effective in these test areas and recommended moving forward with the use of the system throughout their cleanroom facilities. Read the full report below.
| Full Research Report Environmentally Friendly Disinfection of a Pharmaceutical Cleanroom | | ||
More InformationMinncare® Dry Fog™ SystemCleanroom Disinfection Procedure The Minncare Dry Fog system provides an easy to use, high technology solution for clean room and critical area fogging. The combination of our highly effective Minncare cold sterilant chemical and our state of the art Dry Fog delivery system enables users to rapidly and safely deliver Minncare vapor to even the most complex areas. |  |
When other methods failed to meet their room disinfection standards, a large Midwest pharmaceutical plant selected the Minncare Dry Fog System, and it was up to the task. With the advances and innovations in the medical industry , the need for microbiological clean environments has been ever-increasing. Room disinfection and clean environments go hand-in-hand, and many microbiology sensitive industries rely solely on their clean rooms for production, research and development. With strict government regulations, customer liabilities and heavy competition a plant must have a quality disinfection process to continue innovating and producing.
The main reason was to eliminate formaldehyde and to have a faster process. Formaldye takes much longer to return to service because it is a hazardous chemical. The Midwest pharmaceutical plant was searching for a system that would increase automation, improve efficacy and achieve higher levels of reliability compared to their other systems, and decided to try critical area fogging—selecting the Minncare Dry Fog System. One DF system is capable of disinfecting rooms up to 35,000 cubic feet. With droplet sizes of only 7.5 microns, dry fogging droplets bounce off solid surfaces, eliminating excess condensation, the possibility of corrosion, and surface wetting, providing a cleaner, more thorough disinfection process than other fogging methods and manual spray-and-wipe.
The plant had already used two other disinfection procedures, H202 (hydrogen peroxide) and formaldehyde, but the methods left them unsatisfied. To see if the Minncare Dry Fog System was right for them, the plant conducted tests in the staging area for large parts and equipment about to be brought into the clean room, and also the active pharmaceutical ingredient production area, an area requiring exhaustive and thorough disinfection, which previously required the plant to be evacuated for days. The plant found the Dry Fog process to be effective in these test areas and recommended moving forward with the use of the system throughout their cleanroom facilities. Read the full report below.
| Full Research Report Environmentally Friendly Disinfection of a Pharmaceutical Cleanroom |
|
||
More InformationMinncare® Dry Fog™ SystemCleanroom Disinfection Procedure The Minncare Dry Fog system provides an easy to use, high technology solution for clean room and critical area fogging. The combination of our highly effective Minncare cold sterilant chemical and our state of the art Dry Fog delivery system enables users to rapidly and safely deliver Minncare vapor to even the most complex areas. |
|
With exacting standards, wide range of flow rates, and numerous optional components, Mar Cor Purification’s 4400L high purity water system aims to standardize the notoriously unpredictable life sciences water market. Because of the wide range of applications and market applications, the Life Sciences water market, particularly start-up pharmaceutical, lab water makeup, and cosmetics, has historically required the use of custom water systems to meet the varied needs of the end users. Mar Cor Purification, with its 40 years in the high purity water system development and experience in standard product lines, saw the opportunity to meet the needs of this group of water users using a standard product line. Although custom applications are the norm, Mar Cor identified that almost all of these applications fit within a particular flow rate and range of optional components.
Keeping this hard to reach market in mind, Mar Cor developed a standard, low flow rate, price-competi¬tive system with various optional components, capable of meeting the needs of almost any low-flow rate high purity water application. The result of this project, the 4400L, is a standard water platform with three differ¬ent standard flow rates, a distribution system and 10 different standard options available all on a compact single skid, reducing installation costs. The 4400L is designed to produce up to 8 US gpm (30 lpm) at 41°F (5°C) of pure water to a storage and delivery system that can pump up to 80 US gpm (303 lpm) of high quality water to various point of use. The system is designed with the end user in mind, using color touch HMI view coupled with an industrial PLC for a robust control system for operator ease of use. Just like any other Mar Cor platform, the 4400L is built to exacting standards under ISO 9001:2008, and can be executed and installed in a standard lead time. The 4400L System has growing client list since its release last year, and the current trend shows promising potential for future growth
More Information4400 L High Purity Water System2,800 to 11,000 GPD Generation & 28,800 to 115,200 GPD Storage & Delivery The 4400L is designed to produce up to 8 US gpm (30 lpm) at 41°F (5°C) of pure water to a storage and delivery system that can pump up to 80 US gpm (303 lpm) of high quality water to various points of use. The color touch HMI view coupled with an industrial PLC provides a robust control system for operator ease of use. | | ||
With exacting standards, wide range of flow rates, and numerous optional components, Mar Cor Purification’s 4400L high purity water system aims to standardize the notoriously unpredictable life sciences water market. Because of the wide range of applications and market applications, the Life Sciences water market, particularly start-up pharmaceutical, lab water makeup, and cosmetics, has historically required the use of custom water systems to meet the varied needs of the end users. Mar Cor Purification, with its 40 years in the high purity water system development and experience in standard product lines, saw the opportunity to meet the needs of this group of water users using a standard product line. Although custom applications are the norm, Mar Cor identified that almost all of these applications fit within a particular flow rate and range of optional components.
Keeping this hard to reach market in mind, Mar Cor developed a standard, low flow rate, price-competi¬tive system with various optional components, capable of meeting the needs of almost any low-flow rate high purity water application. The result of this project, the 4400L, is a standard water platform with three differ¬ent standard flow rates, a distribution system and 10 different standard options available all on a compact single skid, reducing installation costs. The 4400L is designed to produce up to 8 US gpm (30 lpm) at 41°F (5°C) of pure water to a storage and delivery system that can pump up to 80 US gpm (303 lpm) of high quality water to various point of use. The system is designed with the end user in mind, using color touch HMI view coupled with an industrial PLC for a robust control system for operator ease of use. Just like any other Mar Cor platform, the 4400L is built to exacting standards under ISO 9001:2008, and can be executed and installed in a standard lead time. The 4400L System has growing client list since its release last year, and the current trend shows promising potential for future growth
More Information4400 L High Purity Water System2,800 to 11,000 GPD Generation & 28,800 to 115,200 GPD Storage & Delivery The 4400L is designed to produce up to 8 US gpm (30 lpm) at 41°F (5°C) of pure water to a storage and delivery system that can pump up to 80 US gpm (303 lpm) of high quality water to various points of use. The color touch HMI view coupled with an industrial PLC provides a robust control system for operator ease of use. |
|
||
Mar Cor continually strives to develop innovative technologies designed to improve patient safety and increase provider productivity. As a result, the Millenium HX is the first portable RO water treatment medical device for hemodialysis that can automatically heat disinfect itself and the product water supply tubing to the dialysis machine without being connected to a water supply. This compact RO device represents a quantum leap in reliable water treatment production with the added feature of automated hot water disinfection capability.
The Millenium HX is designed to meet current AAMI/ISO 13959 water quality standards and is FDA cleared for use in Acute and Home dialysis settings. With a full-color LCD, user-friendly touch screen, and automated complete system disinfection that reduces user exposure and increases bacteria control, the system represents the next evolution of Portable Reverse Osmosis devices for hemodialysis.
The Millenium HX joins an already diverse, and still growing, suite of products and systems for hemodialysis, following a trend of increasing innovation in RO technology and patient safety.
The Millenium HX Product Introduction Video can be viewed below
Mar Cor continually strives to develop innovative technologies designed to improve patient safety and increase provider productivity. As a result, the Millenium HX is the first portable RO water treatment medical device for hemodialysis that can automatically heat disinfect itself and the product water supply tubing to the dialysis machine without being connected to a water supply. This compact RO device represents a quantum leap in reliable water treatment production with the added feature of automated hot water disinfection capability.
The Millenium HX is designed to meet current AAMI/ISO 13959 water quality standards and is FDA cleared for use in Acute and Home dialysis settings. With a full-color LCD, user-friendly touch screen, and automated complete system disinfection that reduces user exposure and increases bacteria control, the system represents the next evolution of Portable Reverse Osmosis devices for hemodialysis.
The Millenium HX joins an already diverse, and still growing, suite of products and systems for hemodialysis, following a trend of increasing innovation in RO technology and patient safety.
The Millenium HX Product Introduction Video can be viewed below
With savings of up to $40,000 or more over five years, it’s difficult to reason against having a heat disinfection system for the creation of water for dialysis. Per annual average, clinics utilizing a standard chemical disinfection system will be potentially shelling out nearly $10,000 in on-going annual operating costs. Instead, by adopting Mar Cor Purification’s CWP 100 dialysis water system with heat disinfection technology, during that same time period, clinics on average only spend around $1,900.
This vast disparity in ongoing operating costs is due to the automation of the disinfection process allowed through the heat disinfection technology. Rather than racking up labor hours through weekly chemical sanitization procedures, heat disinfection can be done automatically and off-hours without operator supervision. The CWP 100 heat disinfection system uses more efficient technology, reducing labor hours required, the most expensive cost driver to traditional chemical disinfection systems.
In a typical chemical system, the annual cost of labor hours alone could potentially add up to $5,100— more than two-and-a-half times the amount of the heat disinfection’s total cost. Add in the chemical costs associated with the chemical disinfection process and heat disinfection technology is clearly the more economical option in terms of on-going costs.
In five years, a chemical disinfection system could cost a clinic almost $50,000.
In those same five years, a heat disinfection system could cost that same clinic just shy of $10,000.
Some equations solve themselves.
| More Information Find out more about the potential savings of moving your clinic to a Heat Disinfectable Dialysis Water System by downloading our Heat Disinfection Technology Cost Savings Brochure Also learn more about our line of Central Dialysis Water System featuring Heat Disinfection Technology CWP 100 Dialysis Water System BioPure HX2 Double Pass Dialysis Water System |  | ||
With savings of up to $40,000 or more over five years, it’s difficult to reason against having a heat disinfection system for the creation of water for dialysis. Per annual average, clinics utilizing a standard chemical disinfection system will be potentially shelling out nearly $10,000 in on-going annual operating costs. Instead, by adopting Mar Cor Purification’s CWP 100 dialysis water system with heat disinfection technology, during that same time period, clinics on average only spend around $1,900.
This vast disparity in ongoing operating costs is due to the automation of the disinfection process allowed through the heat disinfection technology. Rather than racking up labor hours through weekly chemical sanitization procedures, heat disinfection can be done automatically and off-hours without operator supervision. The CWP 100 heat disinfection system uses more efficient technology, reducing labor hours required, the most expensive cost driver to traditional chemical disinfection systems.
In a typical chemical system, the annual cost of labor hours alone could potentially add up to $5,100— more than two-and-a-half times the amount of the heat disinfection’s total cost. Add in the chemical costs associated with the chemical disinfection process and heat disinfection technology is clearly the more economical option in terms of on-going costs.
In five years, a chemical disinfection system could cost a clinic almost $50,000.
In those same five years, a heat disinfection system could cost that same clinic just shy of $10,000.
Some equations solve themselves.
| More Information Find out more about the potential savings of moving your clinic to a Heat Disinfectable Dialysis Water System by downloading our Heat Disinfection Technology Cost Savings Brochure Also learn more about our line of Central Dialysis Water System featuring Heat Disinfection Technology CWP 100 Dialysis Water System |
|
||
When a premier supplier of cleanroom garment services sought to reduce operating costs of their high purity water system, they looked to Mar Cor for options and they delivered.
The garment supplier provides cleanroom garments to clients, including those in the semiconductor and pharmaceutical industries. Garments in these industries require high purity water for cleaning to minimize any particulate material.
The Illinois facility had a water system based on large service exchange deionization tanks, which resulted in high monthly costs as their business grew. When the resin in the deionization tanks became exhausted, the tanks needed to be regenerated off-site and replaced by other tanks. This resulted in high operating costs and extended periods of downtime.
However, that all changed in summer 2013.
Mar Cor, a leading supplier of high purity water systems with offices throughout the US and Canada, sent a technical representative to evaluate their needs and suggested they change their approach by installing an on-site, fully integrated RODI high purity water system. The process began with a proposal of a turnkey 35 gpm pretreatment/reverse osmosis/electrodeionization system to be fully installed and operational within three days. The on-site, fully automated system would produce 17 megohm water with low particle and bacteria levels, which would be able to thoroughly clean the gowns with minimal downtime. Because the system was designed as skidded components and fully tested at the factory before shipping, it was installed in the required three day window, minimizing disruption to the business.
After operating successfully for several months, the cleanroom service provider determined the replacement of the garment company’s off-site deionization process with Mar Cor’s high purity water system reduced the company’s water costs by 75%, with the additional benefits of reduced water usage and downtime. Any service needs can be met with support provided from the local service office, so the garment supplier can concentrate on the business end.
Many systems using off-site regenerated resin can be a candidate for an on-site water system. Systems can be installed quickly and operation can be automated. If your facility has high operating costs, consider Mar Cor’s competent, consistent, & compliant products for your company’s high purity water needs.
About Mar Cor Purification
Mar Cor Purification, a wholly‐owned subsidiary of Cantel Medical Corp. (NYSE:CMN), is the largest supplier of dialysis medical water systems in North America. It has service offices in 27 cities in the United States and Canada, with seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Filtration/separation products and disinfectants are provided to the same customer base in addition to a separate worldwide distributor network.
Please visit our High Purity Water page for more information on Mar Cor High Purity Water Systems and how they could be used to reduce operating costs at you facility.
[summary] => [format] => full_html [safe_value] =>
When a premier supplier of cleanroom garment services sought to reduce operating costs of their high purity water system, they looked to Mar Cor for options and they delivered.
The garment supplier provides cleanroom garments to clients, including those in the semiconductor and pharmaceutical industries. Garments in these industries require high purity water for cleaning to minimize any particulate material.
The Illinois facility had a water system based on large service exchange deionization tanks, which resulted in high monthly costs as their business grew. When the resin in the deionization tanks became exhausted, the tanks needed to be regenerated off-site and replaced by other tanks. This resulted in high operating costs and extended periods of downtime.
However, that all changed in summer 2013.
Mar Cor, a leading supplier of high purity water systems with offices throughout the US and Canada, sent a technical representative to evaluate their needs and suggested they change their approach by installing an on-site, fully integrated RODI high purity water system. The process began with a proposal of a turnkey 35 gpm pretreatment/reverse osmosis/electrodeionization system to be fully installed and operational within three days. The on-site, fully automated system would produce 17 megohm water with low particle and bacteria levels, which would be able to thoroughly clean the gowns with minimal downtime. Because the system was designed as skidded components and fully tested at the factory before shipping, it was installed in the required three day window, minimizing disruption to the business.
After operating successfully for several months, the cleanroom service provider determined the replacement of the garment company’s off-site deionization process with Mar Cor’s high purity water system reduced the company’s water costs by 75%, with the additional benefits of reduced water usage and downtime. Any service needs can be met with support provided from the local service office, so the garment supplier can concentrate on the business end.
Many systems using off-site regenerated resin can be a candidate for an on-site water system. Systems can be installed quickly and operation can be automated. If your facility has high operating costs, consider Mar Cor’s competent, consistent, & compliant products for your company’s high purity water needs.
About Mar Cor Purification
Mar Cor Purification, a wholly‐owned subsidiary of Cantel Medical Corp. (NYSE:CMN), is the largest supplier of dialysis medical water systems in North America. It has service offices in 27 cities in the United States and Canada, with seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Filtration/separation products and disinfectants are provided to the same customer base in addition to a separate worldwide distributor network.
Please visit our High Purity Water page for more information on Mar Cor High Purity Water Systems and how they could be used to reduce operating costs at you facility.
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => June 3, 2014 [format] => [safe_value] => June 3, 2014 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [description] => Array ( [value] => Mar Cor’s High Purity Water System Cuts Premier Cleanroom Garment Provider’s Operating Costs By 75% ) [keywords] => Array ( [value] => high purity water, ultrapure water ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454538835 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [24] => stdClass Object ( [vid] => 226 [uid] => 33 [title] => Cantel Medical and Osteosymbionics Announce FDA 510(k) Clearance of Clearshield™ Implant Using Novel REVOX® Sterilization Process [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 226 [type] => news_and_events [language] => und [created] => 1454538939 [changed] => 1461261167 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1461261167 [revision_uid] => 36 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>Little Falls, N.J. and Cleveland, OH, May 28, 2014 - Cantel Medical Corp. (NYSE: CMN) and OsteoSymbionics, a leading designer and manufacturer of innovative, patient-specific craniofacial implants, are pleased to announce FDA (U.S. Food and Drug Administration) 510(k) clearance of OsteoSymbionics’signature ClearShield™ product made from Polymethyl methacrylate (PMMA). ClearShield™ is the first Class II medical device cleared by the FDA utilizing REVOX® Sterilization Solutions’ room temperature peracetic acid/hydrogen peroxide (PAA) vacuum vapor sterilization process. ClearShield™ implants are used in patients who have suffered trauma to the skull, restoring the protective and cosmetic features of the individual’s own bone.
Dorothy Baunach, CEO of OsteoSymbionics says, “REVOX® is the perfect solution for the sterile processing of our ClearShield™ craniofacial implants. More and more hospitals are discontinuing on-site use of ethylene oxide (EtO) sterilization and we needed a solution that would offer fast contract service turnaround and potential for processing at our manufacturing site as well. After much research into sterile processing options we discovered REVOX®, with the right technology and all the resources we needed to help our small, but well-respected company, work toward this ideal solution.
Jorgen Hansen, COO of Cantel Medical comments, “We are pleased that REVOX® Sterilization Solutions is able to facilitate the use of this innovative and critically important device. With increasing sophistication of medical, diagnostic, drug delivery, and implantable devices, REVOX is a timely alternative for manufacturers such as OsteoSymbionics. This 510(k) clearance underscores the safety and efficacy of the REVOX sterilization process and more broadly, our new product and market expansion capabilities within Cantel.”
About OsteoSymbionics
OsteoSymbionics is dedicated to the design, development and fabrication of the highest quality patient-specific craniofacial implants for patients with severe cranial and facial damage. The company’s hard-tissue implants are used by top surgeons at America’s leading hospitals and abroad. More than 850 patients have benefitted from ClearShield™ (PMMA) and PK-Shield™ implants made from Polyether ether ketone (PEEK). OsteoSymbionics also makes a silicone product, STT™, designed to correct temporal hollowing. Using state-of-the-art digital technology and custom software, our biomedical engineering experts work closely with classically trained sculptors and artisans to create implants that precisely match both the surgeon’s plan and the patient’s needs. Cases requiring implants above average in size or difficulty of design are a specialty. OsteoSymbionics is an awarded supplier of its Craniomaxillofacial (CMF) products to Novation, a premiere group purchasing organization serving more than 60,000 members. Founded and located in Cleveland, Ohio, OsteoSymbionics is active in the region’s vibrant community of businesses focused on bioscience technologies and health care services and products. The company is housed within the multi-tenant facility of the Manufacturing Advocacy and Growth Network (MAGNET). For more information about OsteoSymbionics and its products, please call 877-881-6899 or visit our website at www.osteosymbionics.com
About REVOX® Sterilization Solutions
Collaboratively developed and marketed by Cantel subsidiaries Medivators and Mar Cor Purification, REVOX Sterilization Solutions offers the first commercially available room temperature vapor sterilization process. With full contract validation and sterilization services as well as on-site processing potential with multiple chamber configurations, REVOX Sterilization Solutions is positioned to foster increased innovation and production efficiencies for manufacturers of advanced devices. For more information, please visit our website at revoxsterilization.com.
About Cantel Medical Corp.
Cantel Medical (NYS: CMN) is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. Visit our website at www.cantelmedical.com
This press release contains forward‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward‐looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCES: Cantel Medical Corp. and OsteoSymbionics
A downloadable version of this press release can be downloaded from this link, CANTEL MEDICAL AND OSTEOSYMBIONICS Press Release
[summary] => [format] => full_html [safe_value] =>
Little Falls, N.J. and Cleveland, OH, May 28, 2014 - Cantel Medical Corp. (NYSE: CMN) and OsteoSymbionics, a leading designer and manufacturer of innovative, patient-specific craniofacial implants, are pleased to announce FDA (U.S. Food and Drug Administration) 510(k) clearance of OsteoSymbionics’signature ClearShield™ product made from Polymethyl methacrylate (PMMA). ClearShield™ is the first Class II medical device cleared by the FDA utilizing REVOX® Sterilization Solutions’ room temperature peracetic acid/hydrogen peroxide (PAA) vacuum vapor sterilization process. ClearShield™ implants are used in patients who have suffered trauma to the skull, restoring the protective and cosmetic features of the individual’s own bone.
Dorothy Baunach, CEO of OsteoSymbionics says, “REVOX® is the perfect solution for the sterile processing of our ClearShield™ craniofacial implants. More and more hospitals are discontinuing on-site use of ethylene oxide (EtO) sterilization and we needed a solution that would offer fast contract service turnaround and potential for processing at our manufacturing site as well. After much research into sterile processing options we discovered REVOX®, with the right technology and all the resources we needed to help our small, but well-respected company, work toward this ideal solution.
Jorgen Hansen, COO of Cantel Medical comments, “We are pleased that REVOX® Sterilization Solutions is able to facilitate the use of this innovative and critically important device. With increasing sophistication of medical, diagnostic, drug delivery, and implantable devices, REVOX is a timely alternative for manufacturers such as OsteoSymbionics. This 510(k) clearance underscores the safety and efficacy of the REVOX sterilization process and more broadly, our new product and market expansion capabilities within Cantel.”
About OsteoSymbionics
OsteoSymbionics is dedicated to the design, development and fabrication of the highest quality patient-specific craniofacial implants for patients with severe cranial and facial damage. The company’s hard-tissue implants are used by top surgeons at America’s leading hospitals and abroad. More than 850 patients have benefitted from ClearShield™ (PMMA) and PK-Shield™ implants made from Polyether ether ketone (PEEK). OsteoSymbionics also makes a silicone product, STT™, designed to correct temporal hollowing. Using state-of-the-art digital technology and custom software, our biomedical engineering experts work closely with classically trained sculptors and artisans to create implants that precisely match both the surgeon’s plan and the patient’s needs. Cases requiring implants above average in size or difficulty of design are a specialty. OsteoSymbionics is an awarded supplier of its Craniomaxillofacial (CMF) products to Novation, a premiere group purchasing organization serving more than 60,000 members. Founded and located in Cleveland, Ohio, OsteoSymbionics is active in the region’s vibrant community of businesses focused on bioscience technologies and health care services and products. The company is housed within the multi-tenant facility of the Manufacturing Advocacy and Growth Network (MAGNET). For more information about OsteoSymbionics and its products, please call 877-881-6899 or visit our website at www.osteosymbionics.com
About REVOX® Sterilization Solutions
Collaboratively developed and marketed by Cantel subsidiaries Medivators and Mar Cor Purification, REVOX Sterilization Solutions offers the first commercially available room temperature vapor sterilization process. With full contract validation and sterilization services as well as on-site processing potential with multiple chamber configurations, REVOX Sterilization Solutions is positioned to foster increased innovation and production efficiencies for manufacturers of advanced devices. For more information, please visit our website at revoxsterilization.com.
About Cantel Medical Corp.
Cantel Medical (NYS: CMN) is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. Visit our website at www.cantelmedical.com
This press release contains forward‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward‐looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCES: Cantel Medical Corp. and OsteoSymbionics
A downloadable version of this press release can be downloaded from this link, CANTEL MEDICAL AND OSTEOSYMBIONICS Press Release
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => May 28, 2014 [format] => [safe_value] => May 28, 2014 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 163 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_1.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454538939 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://files.shareholder.com/downloads/CNTL/3057417764x0x758239/9d4163b7-bf60-4db1-9f2d-9de843a65da5/CMN_News_2014_5_28_General.pdf [format] => [safe_value] => http://files.shareholder.com/downloads/CNTL/3057417764x0x758239/9d4163b7-bf60-4db1-9f2d-9de843a65da5/CMN_News_2014_5_28_General.pdf ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [title] => Array ( [value] => [node:title] | Mar Cor Purification ) [description] => Array ( [value] => Cantel Medical and Osteosymbionics announce FDA 510(k) clearance of Clearshield™ implant using novel REVOX® Sterilization process ) [keywords] => Array ( [value] => sterile processing, product sterilization ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454538939 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [25] => stdClass Object ( [vid] => 227 [uid] => 33 [title] => Mar Cor Purification Given 510(k) Clearance For Double Pass Heat Disinfectable Water System For Dialysis ‐ Biopure HX2 [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 227 [type] => news_and_events [language] => und [created] => 1454539008 [changed] => 1461090425 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1461090425 [revision_uid] => 36 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>
… New Design Features Energy Conservation and Fully Automated Hot Water Disinfection
Plymouth, MN – May 14, 2014 ‐ Mar Cor Purification, a subsidiary of Cantel Medical (NYS:CMN) announced today that it has been given 510(k) clearance (K133149) from the FDA for the BioPure HX2, a Heat Disinfectable Central Reverse Osmosis (RO) Water System for Dialysis. The BioPure HX2 is a Double Pass RO with automatic hot water disinfection with 4 different modes. Mar Cor had previously been awarded a Class 3 Device License from Health Canada in 2013 for the system, which has been available in the Canadian and international markets for over a year.
The system is designed to produce high quality water and distribution for large capacity applications up to 50 stations and/or 1000 foot loop lengths. An added feature to the design is the ability to operate either as a double pass RO or as a single RO in the event of any issues with either pass. In order to reduce the carbon footprint of the system, the system is outfitted with VFD drives and automatic adjustment of product flow and reject flow based on demand and feed water quality, conserving water and energy. The system will be manufactured in the Mar Cor ISO 13485/CMDCAS registered factory in Burlington, Ontario and conforms to various standards including but not limited to: CAN/CSA C22.2#61010‐1 Standard for Electrical Safety and IEC 61326‐1 Electrical Emissions‐ General Requirements.
John Rickert, VP Medical Sales, noted, “The BioPure HX2 is a next generation, state of the art RO and Distribution system that will meet and exceed the stringent requirements for dialysis and hemodiafiltration water treatment anywhere in the world. I am excited to bring this high technology product to the U.S. market. The system is designed to install quickly, incorporate energy recovery technologies, automatically heat disinfect the entire system, and employs sophisticated hydraulic and pneumatic controls to automatically adjust critical parameters to optimize the system operation.”
About Mar Cor Purification
Mar Cor Purification, a wholly‐owned subsidiary of Cantel Medical Corp. (NYSE:CMN), is the largest supplier of dialysis medical water systems in North America. It has service offices in 27 cities in the United States and Canada, with seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Filtration/separation products and disinfectants are provided to the same customer base in addition to a separate worldwide distributor network. Visit our website at mcpur.com, or find out more about the BioPure HX2 at mcpur.com/dialysis/biopurehx2
About Cantel Medical Corp.
Cantel Medical (NYS: CMN) is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. Visit our website at www.cantelmedical.com
This press release contains forward‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward‐looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE: Mar Cor Purification
Contact information:
Christopher Fournier
cfournier@mcpur.com
Vice President Marketing
Mar Cor Purification
Phone: 978‐453‐9600
[summary] => [format] => full_html [safe_value] =>
… New Design Features Energy Conservation and Fully Automated Hot Water Disinfection
Plymouth, MN – May 14, 2014 ‐ Mar Cor Purification, a subsidiary of Cantel Medical (NYS:CMN) announced today that it has been given 510(k) clearance (K133149) from the FDA for the BioPure HX2, a Heat Disinfectable Central Reverse Osmosis (RO) Water System for Dialysis. The BioPure HX2 is a Double Pass RO with automatic hot water disinfection with 4 different modes. Mar Cor had previously been awarded a Class 3 Device License from Health Canada in 2013 for the system, which has been available in the Canadian and international markets for over a year.
The system is designed to produce high quality water and distribution for large capacity applications up to 50 stations and/or 1000 foot loop lengths. An added feature to the design is the ability to operate either as a double pass RO or as a single RO in the event of any issues with either pass. In order to reduce the carbon footprint of the system, the system is outfitted with VFD drives and automatic adjustment of product flow and reject flow based on demand and feed water quality, conserving water and energy. The system will be manufactured in the Mar Cor ISO 13485/CMDCAS registered factory in Burlington, Ontario and conforms to various standards including but not limited to: CAN/CSA C22.2#61010‐1 Standard for Electrical Safety and IEC 61326‐1 Electrical Emissions‐ General Requirements.
John Rickert, VP Medical Sales, noted, “The BioPure HX2 is a next generation, state of the art RO and Distribution system that will meet and exceed the stringent requirements for dialysis and hemodiafiltration water treatment anywhere in the world. I am excited to bring this high technology product to the U.S. market. The system is designed to install quickly, incorporate energy recovery technologies, automatically heat disinfect the entire system, and employs sophisticated hydraulic and pneumatic controls to automatically adjust critical parameters to optimize the system operation.”
About Mar Cor Purification
Mar Cor Purification, a wholly‐owned subsidiary of Cantel Medical Corp. (NYSE:CMN), is the largest supplier of dialysis medical water systems in North America. It has service offices in 27 cities in the United States and Canada, with seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Filtration/separation products and disinfectants are provided to the same customer base in addition to a separate worldwide distributor network. Visit our website at mcpur.com, or find out more about the BioPure HX2 at mcpur.com/dialysis/biopurehx2
About Cantel Medical Corp.
Cantel Medical (NYS: CMN) is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. Visit our website at www.cantelmedical.com
This press release contains forward‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward‐looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE: Mar Cor Purification
Contact information:
Christopher Fournier
cfournier@mcpur.com
Vice President Marketing
Mar Cor Purification
Phone: 978‐453‐9600
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => May 14, 2014 [format] => [safe_value] => May 14, 2014 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 165 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_3.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454539107 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/main/library/news/HX2510k5-14-14.pdf?ReleaseID=828201 [format] => [safe_value] => http://mcpur.com/main/library/news/HX2510k5-14-14.pdf?ReleaseID=828201 ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [description] => Array ( [value] => Mar Cor Purification Given 510(k) Clearance For Double Pass Heat Disinfectable Water System For Dialysis ‐ Biopure HX2 ) [keywords] => Array ( [value] => double pass RO, heat disinfection ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454539008 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [26] => stdClass Object ( [vid] => 228 [uid] => 33 [title] => Nephros and Mar Cor Purification Announce Distribution Agreement [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 228 [type] => news_and_events [language] => und [created] => 1454539256 [changed] => 1455119120 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455119120 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Mar. 11, 2014 [format] => [safe_value] => Mar. 11, 2014 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 166 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_4.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454539256 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://www.nephros.com/download/press-releases/PR140311_1.pdf [format] => [safe_value] => http://www.nephros.com/download/press-releases/PR140311_1.pdf ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454539256 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [27] => stdClass Object ( [vid] => 229 [uid] => 33 [title] => Mar Cor's introduces the new 4400L High Purity Water, Storage & Delivery System for Ultrapure Water Applications [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 229 [type] => news_and_events [language] => und [created] => 1454539460 [changed] => 1455119866 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455119866 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Mar. 1, 2014 [format] => [safe_value] => Mar. 1, 2014 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/high-purity-water/4400L [format] => [safe_value] => http://mcpur.com/high-purity-water/4400L ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( [und] => Array ( [description] => Array ( [value] => The 4400L RODI high purity water system is a single skid, customizable reverse osmosis system designed to fit any type of ultrapure water application ) [keywords] => Array ( [value] => RODI ,high purity water,lab water makeup,humidification system,high purity water,high purity water system ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454539460 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [28] => stdClass Object ( [vid] => 230 [uid] => 33 [title] => Cantel Medical Announces Novel Sterilization Process Receives ISO Registration [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 230 [type] => news_and_events [language] => und [created] => 1454540150 [changed] => 1455119885 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455119885 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Feb. 24, 2014 [format] => [safe_value] => Feb. 24, 2014 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 167 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_5.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454540150 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://investor.shareholder.com/CNTL/releasedetail.cfm?ReleaseID=828201 [format] => [safe_value] => http://investor.shareholder.com/CNTL/releasedetail.cfm?ReleaseID=828201 ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 128 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540150 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [29] => stdClass Object ( [vid] => 231 [uid] => 33 [title] => Mar Cor's New BioPure LSX Product Introduction Video Highlights the Unique Features [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 231 [type] => news_and_events [language] => und [created] => 1454540299 [changed] => 1455119904 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455119904 [revision_uid] => 50 [body] => Array ( [und] => Array ( [0] => Array ( [value] => [summary] => [format] => full_html [safe_value] => [safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Dec. 15, 2013 [format] => [safe_value] => Dec. 15, 2013 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540299 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [30] => stdClass Object ( [vid] => 232 [uid] => 33 [title] => Read the latest recommendations on "Bacteria Control in Dialysis Water Systems" as featured in Renal Business [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 232 [type] => news_and_events [language] => und [created] => 1454540462 [changed] => 1455119922 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455119922 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Oct. 30 2013 [format] => [safe_value] => Oct. 30 2013 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://www.informaexhibitions.com/ [format] => [safe_value] => http://www.informaexhibitions.com/ ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540462 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [31] => stdClass Object ( [vid] => 233 [uid] => 33 [title] => Mar Cor Purification Announces Award of Health Canada License for Biopure HX2 [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 233 [type] => news_and_events [language] => und [created] => 1454540529 [changed] => 1455119931 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455119931 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => April 13, 2013 [format] => [safe_value] => April 13, 2013 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 168 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_6.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454540529 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/main/library/news/Press_Release_BioPure_HX2_4-8-13F.pdf [format] => [safe_value] => http://mcpur.com/main/library/news/Press_Release_BioPure_HX2_4-8-13F.pdf ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540529 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [32] => stdClass Object ( [vid] => 234 [uid] => 33 [title] => Mar Cor Purification Acquires Hemodialysis Water Business from Siemens Water Technologies [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 234 [type] => news_and_events [language] => und [created] => 1454540598 [changed] => 1455119941 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455119941 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Mar. 25, 2013 [format] => [safe_value] => Mar. 25, 2013 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 169 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_7.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454540598 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/main/library/news/SiemensAcquisitionPressReleaseFINAL.pdf [format] => [safe_value] => http://mcpur.com/main/library/news/SiemensAcquisitionPressReleaseFINAL.pdf ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540598 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [33] => stdClass Object ( [vid] => 235 [uid] => 33 [title] => Mar Cor Purification Launches New USP Purified Water System- Biopure LSX [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 235 [type] => news_and_events [language] => und [created] => 1454540636 [changed] => 1457977574 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1457977574 [revision_uid] => 36 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Jan. 22, 2013 [format] => [safe_value] => Jan. 22, 2013 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 170 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_8.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454540636 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/main/library/news/Press_Release_BioPure_LSX_1-23-13F.pdf [format] => [safe_value] => http://mcpur.com/main/library/news/Press_Release_BioPure_LSX_1-23-13F.pdf ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( [und] => Array ( [title] => Array ( [value] => [node:title] | Mar Cor Purification ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540636 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [34] => stdClass Object ( [vid] => 236 [uid] => 33 [title] => Mar Cor Purification Acquires Eagle Pure Water System, Inc [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 236 [type] => news_and_events [language] => und [created] => 1454540687 [changed] => 1457977899 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1457977899 [revision_uid] => 36 [body] => Array ( [und] => Array ( [0] => Array ( [value] =>
FURTHER ENHANCING ITS NATIONAL WATER PURIFICATION AND FILTRATION GEOGRAPHIC FOOTPRINT IN THE SOUTHEASTERN UNITED STATES
Little Falls, N.J. January 2, 2015 - CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired the assets of Pure Water Solutions, Inc. for a purchase price of $11.9 million in cash consideration. Headquartered in Ridgeland, Mississippi, Pure Water Solutions provides water purification and treatment services for commercial and industrial, laboratory and medical customers out of eight regional offices throughout the Southeastern United States. The company had pre-acquisition unaudited revenues and EBITDA of just over $8 million and $2 million, respectively, for the trailing twelve months. This transaction is expected to be neutral to Cantel's GAAP EPS in FY15 and slightly accretive to its non-GAAP1 EPS in FY15, and is expected to be accretive on both a GAAP and non-GAAP[1] basis thereafter.
Curtis Weitnauer, President and CEO of Mar Cor Purification, stated, "Adding the Pure Water Solutions business and its strategic Southeastern US market presence to our leadership position in life sciences water purification and filtration enables us to better serve our national customers and further expand our commercial and industrial segments. We expect to drive incremental growth with the addition of Mar Cor Purification's capabilities and broad portfolio of products and services."
Rob Simmons, Chief Executive Officer of Pure Water Solutions, will continue as an employee of Mar Cor Purification, where he will assist in the integration and continued service of the Pure Water Solutions customer base and the growth of the broader commercial and industrial water business.
About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 27 cities in the United States and Canada including seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.
About Pure Water Solutions
Pure Water Solutions has been providing High Purity Water Treatment Systems throughout most of the Southern United States since 1969. The Company was founded by Dr. John D. Bower to ensure high water quality for hemodialysis patients in Mississippi. Over the years the company has grown to meet the increasing demand for hemodialysis services in theSoutheast United States. Under the leadership of John M. Bower and subsequently Rob Simmons as CEO, the company has expanded to meet the needs of commercial and industrial customers in the region. Pure Water Solutions customers range from large industrial companies with complex ultrapure water treatment needs to those with simple deionized water applications. Pure Water Solutions has an extensive network of regional offices with trained sales and service professionals. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
[1] Non-GAAP EPS represents Earnings Per Share excluding acquisition-related intangible amortization as well as transaction-related expenses. For further disclosure regarding non-GAAP items please refer to Cantel Medical's latest quarterly filing.
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/cantel-medical-acquires-pure-water-solutions-inc-300014913.html SOURCE Cantel Medical Corp.
[summary] => [format] => full_html [safe_value] =>FURTHER ENHANCING ITS NATIONAL WATER PURIFICATION AND FILTRATION GEOGRAPHIC FOOTPRINT IN THE SOUTHEASTERN UNITED STATES
Little Falls, N.J. January 2, 2015 - CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired the assets of Pure Water Solutions, Inc. for a purchase price of $11.9 million in cash consideration. Headquartered in Ridgeland, Mississippi, Pure Water Solutions provides water purification and treatment services for commercial and industrial, laboratory and medical customers out of eight regional offices throughout the Southeastern United States. The company had pre-acquisition unaudited revenues and EBITDA of just over $8 million and $2 million, respectively, for the trailing twelve months. This transaction is expected to be neutral to Cantel's GAAP EPS in FY15 and slightly accretive to its non-GAAP1 EPS in FY15, and is expected to be accretive on both a GAAP and non-GAAP[1] basis thereafter.
Curtis Weitnauer, President and CEO of Mar Cor Purification, stated, "Adding the Pure Water Solutions business and its strategic Southeastern US market presence to our leadership position in life sciences water purification and filtration enables us to better serve our national customers and further expand our commercial and industrial segments. We expect to drive incremental growth with the addition of Mar Cor Purification's capabilities and broad portfolio of products and services."
Rob Simmons, Chief Executive Officer of Pure Water Solutions, will continue as an employee of Mar Cor Purification, where he will assist in the integration and continued service of the Pure Water Solutions customer base and the growth of the broader commercial and industrial water business.
About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com
About Mar Cor Purification, Inc.
Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 27 cities in the United States and Canada including seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.
About Pure Water Solutions
Pure Water Solutions has been providing High Purity Water Treatment Systems throughout most of the Southern United States since 1969. The Company was founded by Dr. John D. Bower to ensure high water quality for hemodialysis patients in Mississippi. Over the years the company has grown to meet the increasing demand for hemodialysis services in theSoutheast United States. Under the leadership of John M. Bower and subsequently Rob Simmons as CEO, the company has expanded to meet the needs of commercial and industrial customers in the region. Pure Water Solutions customers range from large industrial companies with complex ultrapure water treatment needs to those with simple deionized water applications. Pure Water Solutions has an extensive network of regional offices with trained sales and service professionals. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
[1] Non-GAAP EPS represents Earnings Per Share excluding acquisition-related intangible amortization as well as transaction-related expenses. For further disclosure regarding non-GAAP items please refer to Cantel Medical's latest quarterly filing.
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/cantel-medical-acquires-pure-wat... SOURCE Cantel Medical Corp.
[safe_summary] => ) ) ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Jan. 7, 2013 [format] => [safe_value] => Jan. 7, 2013 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 171 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_9.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454540687 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/main/library/news/Press_Release_Eagle_Pure_Water_1-7-13.pdf [format] => [safe_value] => http://mcpur.com/main/library/news/Press_Release_Eagle_Pure_Water_1-7-13.pdf ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540687 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [35] => stdClass Object ( [vid] => 237 [uid] => 33 [title] => Cantel Medical, Named To The Forbes 2012 List Of The “100 Best Small Companies In America” [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 237 [type] => news_and_events [language] => und [created] => 1454540756 [changed] => 1456345159 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1456345159 [revision_uid] => 36 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Nov.1 2012 [format] => [safe_value] => Nov.1 2012 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 172 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_10.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454540756 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/main/library/news/MCP_Parent_Cantel_Named_to_Forbes_List_11-8-12.pdf [format] => [safe_value] => http://mcpur.com/main/library/news/MCP_Parent_Cantel_Named_to_Forbes_List_11-8-12.pdf ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( [und] => Array ( [title] => Array ( [value] => [node:title] | Mar Cor Purification ) ) ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540756 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [36] => stdClass Object ( [vid] => 238 [uid] => 33 [title] => New ISO Water Quality Standard for Hemodialysis Adopted [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 238 [type] => news_and_events [language] => und [created] => 1454540796 [changed] => 1455119966 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455119966 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => July 6, 2012 [format] => [safe_value] => July 6, 2012 ) ) ) [field_press_release] => Array ( ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/dialysis/iso13059 [format] => [safe_value] => http://mcpur.com/dialysis/iso13059 ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540796 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [37] => stdClass Object ( [vid] => 239 [uid] => 33 [title] => MCP Opens New Office and Training Center in Colorado [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 239 [type] => news_and_events [language] => und [created] => 1454540838 [changed] => 1455119996 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455119996 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => June 6, 2011 [format] => [safe_value] => June 6, 2011 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 173 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_11.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454540838 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/main/library/news/MCP_Opens_New_Office_and_Training_Center_in_Colorado_6-14-11_Final.pdf [format] => [safe_value] => http://mcpur.com/main/library/news/MCP_Opens_New_Office_and_Training_Center_in_Colorado_6-14-11_Final.pdf ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540838 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => ) [38] => stdClass Object ( [vid] => 240 [uid] => 33 [title] => MCP Announces Launch of First Heat Disinfectable Portable RO for Dialysis [log] => [status] => 1 [comment] => 1 [promote] => 1 [sticky] => 0 [nid] => 240 [type] => news_and_events [language] => und [created] => 1454540875 [changed] => 1455120004 [tnid] => 0 [translate] => 0 [revision_timestamp] => 1455120004 [revision_uid] => 50 [body] => Array ( ) [field_event_date] => Array ( [und] => Array ( [0] => Array ( [value] => Mar. 15, 2011 [format] => [safe_value] => Mar. 15, 2011 ) ) ) [field_press_release] => Array ( [und] => Array ( [0] => Array ( [fid] => 174 [uid] => 33 [filename] => pdf.png [uri] => public://pressReleases/pdf_12.png [filemime] => image/png [filesize] => 2422 [status] => 1 [timestamp] => 1454540875 [rdf_mapping] => Array ( ) [display] => 1 [description] => ) ) ) [field_outside_link] => Array ( [und] => Array ( [0] => Array ( [value] => http://mcpur.com/main/library/news/MCP_Launches_First_Hot_Water_Disinfect_Portable_RO_for_Dialysiis_3-1-11_Final.pdf [format] => [safe_value] => http://mcpur.com/main/library/news/MCP_Launches_First_Hot_Water_Disinfect_Portable_RO_for_Dialysiis_3-1-11_Final.pdf ) ) ) [field_archive] => Array ( [und] => Array ( [0] => Array ( [tid] => 127 ) ) ) [metatags] => Array ( ) [rdf_mapping] => Array ( [rdftype] => Array ( [0] => sioc:Item [1] => foaf:Document ) [title] => Array ( [predicates] => Array ( [0] => dc:title ) ) [created] => Array ( [predicates] => Array ( [0] => dc:date [1] => dc:created ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [changed] => Array ( [predicates] => Array ( [0] => dc:modified ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) [body] => Array ( [predicates] => Array ( [0] => content:encoded ) ) [uid] => Array ( [predicates] => Array ( [0] => sioc:has_creator ) [type] => rel ) [name] => Array ( [predicates] => Array ( [0] => foaf:name ) ) [comment_count] => Array ( [predicates] => Array ( [0] => sioc:num_replies ) [datatype] => xsd:integer ) [last_activity] => Array ( [predicates] => Array ( [0] => sioc:last_activity_date ) [datatype] => xsd:dateTime [callback] => date_iso8601 ) ) [cid] => 0 [last_comment_timestamp] => 1454540875 [last_comment_name] => [last_comment_uid] => 33 [comment_count] => 0 [name] => adam [picture] => 0 [data] => [entity_view_prepared] => 1 ) )
August 11, 2016
Mar Cor to Host Live Webinar on "Cost Reduction Options for USP Water Systems" on Sept. 1, 2016
April 12, 2016
New Video Highlights ROVER Dialysis Water Transport System
March 30, 2016
Mar Cor Purification Launches New Dialysis Water Transport System
Jan. 14, 2016
Cantel Medical Subsidiary Mar Cor Purification Releases New 2016 Digital Dialysis Water Catalog and Price Guide
Mar Cor Purification, a Cantel Medical Company provides water purification systems and service to medical, pharmaceutical and other bacteria controlled applications. Mar Cor additionally provides filtration/separation and disinfectant technologies to the medical and life science market through a worldwide distributor network.
Mar Cor Purification is dedicated to providing innovative filtration, water, and disinfection technologies that deliver the best solutions for our customers.
